Interferon-alpha	B-protein
activates	O
multiple	O
STAT	B-protein
proteins	I-protein
and	O
upregulates	O
proliferation-associated	O
IL-2Ralpha	B-protein
,	O
c-myc	B-DNA
,	I-DNA
and	I-DNA
pim-1	I-DNA
genes	I-DNA
in	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Interferon-alpha	B-protein
(	O
IFN-alpha	B-protein
)	O
is	O
a	O
pleiotropic	B-protein
cytokine	I-protein
that	O
has	O
antiviral	O
,	O
antiproliferative	O
,	O
and	O
immunoregulatory	B-protein
functions	O
.	O

There	O
is	O
increasing	O
evidence	O
that	O
IFN-alpha	B-protein
has	O
an	O
important	O
role	O
in	O
T-cell	O
biology	O
.	O

We	O
have	O
analyzed	O
the	O
expression	O
of	O
IL-2Ralpha	B-protein
,	O
c-myc	B-DNA
,	O
and	O
pim-1	B-DNA
genes	I-DNA
in	O
anti-CD3-activated	B-cell_type
human	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
.	O

The	O
induction	O
of	O
these	O
genes	O
is	O
associated	O
with	O
interleukin-2	B-protein
(	O
IL-2	B-protein
)	O
-induced	O
T-cell	O
proliferation	O
.	O

Treatment	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
with	O
IFN-alpha	B-protein
,	O
IL-2	B-protein
,	O
IL-12	B-protein
,	O
and	O
IL-15	B-protein
upregulated	O
IL-2Ralpha	B-protein
,	O
c-myc	B-DNA
,	O
and	O
pim-1	B-DNA
gene	I-DNA
expression	O
.	O

IFN-alpha	B-protein
also	O
sensitized	B-cell_line
T	I-cell_line
cells	I-cell_line
to	O
IL-2	B-protein
-induced	O
proliferation	O
,	O
further	O
suggesting	O
that	O
IFN-alpha	B-protein
may	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
T-cell	O
mitogenesis	O
.	O

When	O
we	O
analyzed	O
the	O
nature	O
of	O
STAT	B-protein
proteins	I-protein
capable	O
of	O
binding	O
to	O
IL-2Ralpha	B-protein
,	O
pim-1	B-DNA
,	I-DNA
and	I-DNA
IRF-1	I-DNA
GAS	I-DNA
elements	I-DNA
after	O
cytokine	B-protein
stimulation	O
,	O
we	O
observed	O
IFN-alpha	B-protein
-induced	O
binding	O
of	O
STAT1	B-protein
,	O
STAT3	B-protein
,	O
and	O
STAT4	B-protein
,	O
but	O
not	O
STAT5	B-protein
to	O
all	O
of	O
these	O
elements	O
.	O

Yet	O
,	O
IFN-alpha	B-protein
was	O
able	O
to	O
activate	O
binding	O
of	O
STAT5	B-protein
to	O
the	O
high-affinity	O
IFP53	O
GAS	O
site	O
.	O

IFN-alpha	B-protein
enhanced	O
tyrosine	O
phosphorylation	O
of	O
STAT1	O
,	O
STAT3	B-protein
,	O
STAT4	B-protein
,	O
STAT5a	B-protein
,	O
and	O
STAT5b	B-protein
.	O

IL-12	B-protein
induced	O
STAT4	B-protein
and	O
IL-2	B-protein
and	O
IL-15	B-protein
induced	O
STAT5	B-protein
binding	O
to	O
the	O
GAS	B-DNA
elements	I-DNA
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
IFN-alpha	B-protein
,	O
IL-2	B-protein
,	O
IL-12	B-protein
,	O
and	O
IL-15	B-protein
have	O
overlapping	O
activities	O
on	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

These	O
findings	O
thus	O
emphasize	O
the	O
importance	O
of	O
IFN-alpha	B-protein
as	O
a	O
T-cell	B-protein
regulatory	I-protein
cytokine	I-protein
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IMMUNOBIOLOGY	NULL
Interferon-a	NULL
«	NULL
Activates	NULL
Multiple	NULL
STAT	NULL
Proteins	NULL
and	NULL
Upregulates	NULL
Proliferation-Associated	NULL
IL-2Ra	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
Genes	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
By	NULL
Sampsa	NULL
Matikainen	NULL
,	NULL
Timo	NULL
Sareneva	NULL
,	NULL
Tapani	NULL
Ronni	NULL
,	NULL
Anne	NULL
Lehtonen	NULL
,	NULL
Paivi	NULL
J.	NULL
Koskinen	NULL
,	NULL
and	NULL
Ilkka	NULL
Julkunen	NULL
Interferon-	NULL
«	NULL
(	NULL
IFN-	NULL
«	NULL
)	NULL
is	NULL
a	NULL
pleiotropic	NULL
cytokine	NULL
that	NULL
has	NULL
antiviral	NULL
,	NULL
antiproliferative	NULL
,	NULL
and	NULL
immunoregulatory	NULL
functions	NULL
.	NULL

There	NULL
is	NULL
increasing	NULL
evidence	NULL
that	NULL
IFN-	NULL
«	NULL
has	NULL
an	NULL
important	NULL
role	NULL
in	NULL
T-cell	NULL
biology	NULL
.	NULL

We	NULL
have	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
/L-2Re	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
genes	NULL
in	NULL
anti-CD3-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
these	NULL
genes	NULL
is	NULL
associated	NULL
with	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
-induced	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Treatment	NULL
of	NULL
T	NULL
lymphocytes	NULL
with	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
upregulated	NULL
/L-2R	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
.	NULL

IFN-	NULL
«	NULL
also	NULL
sensitized	NULL
T	NULL
cells	NULL
to	NULL
IL-2-induced	NULL
proliferation	NULL
,	NULL
further	NULL
suggesting	NULL
that	NULL
IFN-	NULL
«	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T-cell	NULL
mitogenesis	NULL
.	NULL

When	NULL
we	NULL
analyzed	NULL
the	NULL
nature	NULL
of	NULL
STAT	NULL
proteins	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
L-2RMx	NULL
,	NULL
pim-1	NULL
,	NULL
and	NULL
IRF-1	NULL
GAS	NULL
NTERFERON-a	NULL
«	NULL
(	NULL
IFN-	NULL
«	NULL
)	NULL
has	NULL
antiviral	NULL
,	NULL
antiproliferative	NULL
,	NULL
and	NULL
immunomodulatory	NULL
functions	NULL
.	NULL
``	NULL

''	NULL
IFN-	NULL
«	NULL
is	NULL
produced	NULL
in	NULL
the	NULL
course	NULL
of	NULL
immune	NULL
response	NULL
,	NULL
especially	NULL
during	NULL
viral	NULL
infections	NULL
.	NULL

Macrophages	NULL
and	NULL
other	NULL
antigen-presenting	NULL
cells	NULL
are	NULL
the	NULL
main	NULL
cellular	NULL
sources	NULL
of	NULL
IFN-	NULL
«	NULL
.	NULL

Immunomodulatory	NULL
functions	NULL
of	NULL
IFN-a	NULL
«	NULL
include	NULL
the	NULL
enhancement	NULL
of	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cell	NULL
and	NULL
T-cell	NULL
cytotoxicity	NULL
,	NULL
``	NULL
and	NULL
knockout	NULL
mice	NULL
lacking	NULL
a	NULL
functional	NULL
type	NULL
I	NULL
IFN	NULL
receptor	NULL
were	NULL
unable	NULL
to	NULL
generate	NULL
a	NULL
cytotoxic	NULL
T-lymphocyte	NULL
response	NULL
to	NULL
lymphocytic	NULL
choriomeningitis	NULL
virus	NULL
.	NULL

IFN-a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
promote	NULL
Th1-type	NULL
immune	NULL
responses	NULL
,	NULL
eg	NULL
,	NULL
by	NULL
inducing	NULL
interleukin-12	NULL
(	NULL
IL-12	NULL
)	NULL
receptor	NULL
B2	NULL
chain	NULL
and	NULL
IFN-y	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

IL-2	NULL
is	NULL
the	NULL
major	NULL
growth	NULL
factor	NULL
for	NULL
T	NULL
lymphocytes	NULL
.	NULL

IL-2	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
several	NULL
signaling	NULL
pathways	NULL
,	NULL
including	NULL
the	NULL
Janus	NULL
tyrosine	NULL
kinase-signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Jak-STAT	NULL
)	NULL
path-way	NULL
.	NULL
``	NULL

Binding	NULL
of	NULL
IL-2	NULL
to	NULL
its	NULL
receptor	NULL
activates	NULL
Jak1	NULL
and	NULL
Jak3	NULL
tyrosine	NULL
kinases	NULL
,	NULL
leading	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
dimeriza-tion	NULL
,	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT5	NULL
proteins	NULL
.	NULL

The	NULL
role	NULL
of	NULL
STATS	NULL
in	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
is	NULL
controversial	NULL
,	NULL
'	NULL
>	NULL
``	NULL
but	NULL
recent	NULL
studies	NULL
with	NULL
STATSa-deficient	NULL
mice	NULL
suggest	NULL
that	NULL
STAT5a	NULL
is	NULL
involved	NULL
in	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Splenocytes	NULL
from	NULL
STAT	NULL
S5a-deficient	NULL
mice	NULL
show	NULL
decreased	NULL
proliferative	NULL
response	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Virology	NULL
,	NULL
National	NULL
Public	NULL
Health	NULL
Institute	NULL
,	NULL
Helsinki	NULL
,	NULL
Finland	NULL
;	NULL
and	NULL
Turku	NULL
Centre	NULL
for	NULL
Biotechnology	NULL
,	NULL
University	NULL
of	NULL
Turku	NULL
and	NULL
Abo	NULL
Akademi	NULL
University	NULL
,	NULL
Turku	NULL
,	NULL
Finland	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
the	NULL
Academy	NULL
of	NULL
Finland	NULL
,	NULL
the	NULL
Sigrid	NULL
Juselius	NULL
Foundation	NULL
,	NULL
the	NULL
Technology	NULL
Development	NULL
Center	NULL
of	NULL
Finland	NULL
,	NULL
the	NULL
Jenny	NULL
and	NULL
Aniti	NULL
Wihuri	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Finnish	NULL
Cancer	NULL
Organizations	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Sampsa	NULL
Matikainen	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Virology	NULL
,	NULL
National	NULL
Public	NULL
Health	NULL
Institute	NULL
,	NULL
Mannerheimintie	NULL
166	NULL
,	NULL
FIN-00300	NULL
Helsinki	NULL
,	NULL
Finland	NULL
;	NULL
e-mail	NULL
:	NULL
sampsa.matikainen	NULL
@	NULL
ktl.fi	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/99/9306-0022	NULL
$	NULL
3.00/0	NULL
1980	NULL
elements	NULL
after	NULL
cytokine	NULL
stimulation	NULL
,	NULL
we	NULL
observed	NULL
IFN-	NULL
«	NULL
-induced	NULL
binding	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STATA	NULL
,	NULL
but	NULL
not	NULL
STATS	NULL
to	NULL
all	NULL
of	NULL
these	NULL
elements	NULL
.	NULL

Yet	NULL
,	NULL
IFN-	NULL
«	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
binding	NULL
of	NULL
STATS	NULL
to	NULL
the	NULL
high-affinity	NULL
IFP53	NULL
GAS	NULL
site	NULL
.	NULL

IFN-	NULL
«	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
STATS5a	NULL
,	NULL
and	NULL
STATS5b	NULL
.	NULL

IL-12	NULL
induced	NULL
STAT4	NULL
and	NULL
IL-2	NULL
and	NULL
IL-15	NULL
induced	NULL
STATS	NULL
binding	NULL
to	NULL
the	NULL
GAS	NULL
elements	NULL
.	NULL

Taken	NULL
to-gether	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL~15	NULL
have	NULL
overlapping	NULL
activities	NULL
on	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
emphasize	NULL
the	NULL
importance	NULL
of	NULL
IFN-	NULL
«	NULL
as	NULL
a	NULL
T-cell	NULL
regulatory	NULL
cytokine	NULL
.	NULL

©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

to	NULL
IL-2	NULL
,	NULL
a	NULL
result	NULL
of	NULL
impaired	NULL
expression	NULL
of	NULL
IL-2	NULL
receptor	NULL
a	NULL
(	NULL
IL-2Ra	NULL
)	NULL
chain	NULL
.	NULL
``	NULL

IL-2	NULL
signals	NULL
via	NULL
a	NULL
specific	NULL
receptor	NULL
,	NULL
the	NULL
high-affinity	NULL
form	NULL
of	NULL
which	NULL
is	NULL
composed	NULL
of	NULL
three	NULL
subunits	NULL
,	NULL
«	NULL
(	NULL
CD25	NULL
)	NULL
,	NULL
B	NULL
(	NULL
CD122	NULL
)	NULL
,	NULL
and	NULL
``	NULL
¥	NULL
(	NULL
Vcommon	NULL
)	NULL
Chains	NULL
.	NULL

Whereas	NULL
the	NULL
B	NULL
and	NULL
y	NULL
chains	NULL
are	NULL
constitutively	NULL
expressed	NULL
in	NULL
resting	NULL
T	NULL
lymphocytes	NULL
,	NULL
the	NULL
«	NULL
chain	NULL
is	NULL
expressed	NULL
only	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

Both	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
and	NULL
IL-2	NULL
treatment	NULL
are	NULL
able	NULL
to	NULL
induce	NULL
a	NULL
chain	NULL
gene	NULL
expression	NULL
.	NULL

IL-2Ra	NULL
chain	NULL
is	NULL
required	NULL
for	NULL
the	NULL
high-affinity	NULL
binding	NULL
of	NULL
IL-2	NULL
and	NULL
it	NULL
is	NULL
essential	NULL
for	NULL
optimal	NULL
proliferative	NULL
responses	NULL
of	NULL
the	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
A	NULL
human	NULL
immune	NULL
disorder	NULL
,	NULL
characterized	NULL
by	NULL
decreased	NULL
numbers	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
,	NULL
arises	NULL
from	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
coding	NULL
for	NULL
the	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
.	NULL
``	NULL

''	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
several	NULL
IL-2-responsive	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
c-myc	NULL
and	NULL
pim-1..5	NULL
``	NULL
The	NULL
c-myc	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
proliferating	NULL
cells	NULL
,	NULL
and	NULL
it	NULL
is	NULL
activated	NULL
in	NULL
many	NULL
types	NULL
of	NULL
human	NULL
and	NULL
animal	NULL
neoplasia	NULL
,	NULL
including	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
.	NULL
``	NULL

The	NULL
pim-1	NULL
gene	NULL
encodes	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
Studies	NULL
with	NULL
transgenic	NULL
mice	NULL
have	NULL
demonstrated	NULL
that	NULL
pim-	NULL
]	NULL
can	NULL
also	NULL
act	NULL
as	NULL
an	NULL
oncogene	NULL
in	NULL
synergy	NULL
with	NULL
c-myc	NULL
,	NULL
N-myc	NULL
,	NULL
or	NULL
bei-2	NULL
to	NULL
induce	NULL
B-	NULL
and	NULL
T-cell	NULL
lymphomas	NULL
.	NULL

?	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
overexpression	NULL
of	NULL
pim-1	NULL
can	NULL
accelerate	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cell	NULL
proliferation	NULL
by	NULL
enhancing	NULL
cell	NULL
survival	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Both	NULL
c-Myc	NULL
and	NULL
Pim-1	NULL
proteins	NULL
may	NULL
thus	NULL
have	NULL
important	NULL
roles	NULL
in	NULL
mediating	NULL
cytokine-induced	NULL
mitogenic	NULL
signals	NULL
.	NULL

Although	NULL
IFN-a	NULL
«	NULL
is	NULL
an	NULL
important	NULL
T-cell	NULL
regulatory	NULL
cytokine	NULL
,	NULL
most	NULL
studies	NULL
so	NULL
far	NULL
regarding	NULL
IFN-	NULL
«	NULL
signaling	NULL
and	NULL
gene	NULL
activation	NULL
have	NULL
been	NULL
performed	NULL
using	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
cytokine-dependent	NULL
gene	NULL
expression	NULL
in	NULL
anti-CD3-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
focusing	NULL
on	NULL
genes	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
T-cell	NULL
mitogenesis	NULL
.	NULL

We	NULL
show	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
IFN-	NULL
«	NULL
,	NULL
also	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
induce	NULL
IL-2Ra	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
IFN-	NULL
«	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
STATA	NULL
,	NULL
STAT	NULL
5a	NULL
,	NULL
and	NULL
STAT	NULL
5b	NULL
and	NULL
enhances	NULL
their	NULL
binding	NULL
to	NULL
the	NULL
IFN-y	NULL
activated	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
elements	NULL
of	NULL
the	NULL
IFN-o-responsive	NULL
genes	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
6	NULL
(	NULL
March	NULL
15	NULL
)	NULL
,	NULL
1999	NULL
:	NULL
pp	NULL
1980-1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

INF-	NULL
«	NULL
ACTIVATES	NULL
MULTIPLE	NULL
STAT	NULL
PROTEINS	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
T-cell	NULL
culture	NULL
.	NULL

Leukocyte-rich	NULL
buffy	NULL
coats	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
blood	NULL
donors	NULL
(	NULL
Finnish	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
,	NULL
Helsinki	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
using	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
AB	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
removed	NULL
by	NULL
adherence	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
nylon	NULL
wool	NULL
columns	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
anti-CD3	NULL
monoclonal	NULL
antibodies	NULL
containing	NULL
ascites	NULL
fluid	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Matti	NULL
Kaartinen	NULL
,	NULL
University	NULL
of	NULL
Helsinki	NULL
,	NULL
Helsinki	NULL
,	NULL
Finland	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Integro	NULL
,	NULL
Zaandam	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
and	NULL
100	NULL
IU/mL	NULL
IL-2	NULL
for	NULL
5	NULL
to	NULL
6	NULL
days	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
further	NULL
expanded	NULL
for	NULL
3	NULL
to	NULL
5	NULL
days	NULL
with	NULL
RPMI	NULL
supplemented	NULL
with	NULL
IL-2	NULL
.	NULL

As	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
,	NULL
more	NULL
than	NULL
99	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
CD3*	NULL
,	NULL
consisting	NULL
of	NULL
CD4*	NULL
(	NULL
30	NULL
%	NULL
)	NULL
and	NULL
CD8	NULL
*	NULL
(	NULL
70	NULL
%	NULL
)	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
IL-2-containing	NULL
medium	NULL
12	NULL
to	NULL
16	NULL
hours	NULL
before	NULL
cytokine	NULL
stimulation	NULL
.	NULL

In	NULL
each	NULL
experiment	NULL
,	NULL
T	NULL
cells	NULL
from	NULL
two	NULL
to	NULL
four	NULL
donors	NULL
were	NULL
used	NULL
.	NULL

Cytokines	NULL
.	NULL

Highly	NULL
purified	NULL
human	NULL
leukocyte	NULL
IFN-	NULL
«	NULL
(	NULL
13	NULL
X	NULL
105	NULL
IU/mL	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr	NULL
Hannele	NULL
(	NULL
Finnish	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
,	NULL
Helsinki	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

IFN-B	NULL
(	NULL
0.2	NULL
X	NULL
106	NULL
IU/mL	NULL
)	NULL
was	NULL
from	NULL
Bioferon	NULL
GmbH	NULL
&	NULL
Co	NULL
(	NULL
Laupheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Human	NULL
recombi-nant	NULL
IL-12	NULL
(	NULL
rIL-12	NULL
)	NULL
and	NULL
rIL-15	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Abingdon	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
IL-2	NULL
from	NULL
Chiron	NULL
Corp	NULL
(	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
cytokine	NULL
concentrations	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
,	NULL
unless	NULL
otherwise	NULL
indi-cated	NULL
:	NULL
IFN-	NULL
«	NULL
(	NULL
100	NULL
IU/mL	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
100	NULL
IU/mL	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
and	NULL
IL-15	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

'T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
cytokines	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
3	NULL
hours	NULL
after	NULL
stimulation	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
guanidium	NULL
isothiocyanate	NULL
lysis	NULL
followed	NULL
by	NULL
centrifugation	NULL
through	NULL
CsCl	NULL
cushion	NULL
.	NULL

?	NULL
``	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
quantitated	NULL
photometrically	NULL
and	NULL
samples	NULL
containing	NULL
equal	NULL
amounts	NULL
of	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
size	NULL
fractionated	NULL
on	NULL
a	NULL
1.0	NULL
%	NULL
formaldehyde-agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond	NULL
;	NULL
Amersham	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
cDNA	NULL
probes	NULL
encoding	NULL
human	NULL
IL-2Re	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
.	NULL

EtBr	NULL
staining	NULL
of	NULL
rRNA	NULL
bands	NULL
was	NULL
used	NULL
to	NULL
ensure	NULL
equal	NULL
RNA	NULL
loading	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
2P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
)	NULL
using	NULL
a	NULL
random	NULL
primed	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
hybridized	NULL
under	NULL
conditions	NULL
of	NULL
high	NULL
stringency	NULL
(	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5X	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
5X	NULL
SSPE	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
twice	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
once	NULL
at	NULL
60°C	NULL
in	NULL
1X	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
minutes	NULL
each	NULL
time	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
AR	NULL
X-Omat	NULL
films	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
at	NULL
-70°C	NULL
using	NULL
intensifying	NULL
screen	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
``	NULL
and	NULL
nuclear	NULL
protein/DNA	NULL
binding	NULL
reactions	NULL
``	NULL
?	NULL

were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

IFP	NULL
53	NULL
GAS	NULL
(	NULL
5'-GATCAATCACCCAGATTCTCAGAAA-CACTT-3	NULL
'	NULL
)	NULL
,	NULL
IRF-1	NULL
GAS	NULL
(	NULL
5-AGCTTCAGCCTGATTTCCCCGAAAT-GACGGA-3	NULL
'	NULL
)	NULL
,	NULL
pim-1	NULL
GAS	NULL
(	NULL
5-ACACACATCCCTTCCCAGAAAT-CAGGATTC-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
IL-2R	NULL
«	NULL
GAS-c/GAS-n	NULL
(	NULL
5-TTTCTTCTA-GGAAGTACCAAACATTTCTGATAATAGAA-3	NULL
'	NULL
)	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
with	NULL
an	NULL
IBI	NULL
oligonucleotide	NULL
synthesizer	NULL
(	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
purified	NULL
on	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
8	NULL
mol/L	NULL
urea	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
labeled	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
by	NULL
elecrophoresis	NULL
on	NULL
6	NULL
%	NULL
nondenatur-ing	NULL
low-ionic	NULL
strength	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Antibodies	NULL
used	NULL
in	NULL
supershift	NULL
experiments	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
anti-STAT1	NULL
(	NULL
se-345X	NULL
)	NULL
,	NULL
anti-STAT2	NULL
(	NULL
sc-839X	NULL
)	NULL
,	NULL
anti-STAT3	NULL
(	NULL
sc-482X	NULL
)	NULL
,	NULL
anti-STAT4	NULL
(	NULL
sc-486X	NULL
)	NULL
,	NULL
anti-STAT5b	NULL
(	NULL
sc-835X	NULL
;	NULL
recognizes	NULL
both	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
)	NULL
,	NULL
and	NULL
anti-STAT6	NULL
(	NULL
sc-621X	NULL
%	NULL
)	NULL
.	NULL

In	NULL
supershift	NULL
experiments	NULL
,	NULL
antibod-	NULL
1981	NULL
ies	NULL
(	NULL
1/20	NULL
dilution	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
cytokines	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
immunoprecipi-tation	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
containing	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
cleared	NULL
by	NULL
microfuge	NULL
centrifugation	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT1	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
anti-STAT3	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
anti-STAT4	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
anti-STAT5a	NULL
(	NULL
71-2400	NULL
;	NULL
ZYMED	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
or	NULL
anti-STAT5b	NULL
(	NULL
71-2500	NULL
;	NULL
ZYMED	NULL
)	NULL
antibodies	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
using	NULL
the	NULL
Laemmli	NULL
buffer	NULL
system	NULL
``	NULL
``	NULL
and	NULL
transferred	NULL
electrophoretically	NULL
onto	NULL
Immobilon	NULL
membranes	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Biotinylated	NULL
antihuman	NULL
IL-2Ra	NULL
polyclonal	NULL
antibody	NULL
(	NULL
0.2	NULL
ug/mL	NULL
;	NULL
BAF223	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
was	NULL
allowed	NULL
to	NULL
bind	NULL
in	NULL
PBS	NULL
containing	NULL
3	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
peroxidase-conjugated	NULL
streptavidin	NULL
(	NULL
1/2,000	NULL
dilution	NULL
;	NULL
016-030-084	NULL
;	NULL
Jackson	NULL
ImmunoResearch	NULL
Laborato-ries	NULL
,	NULL
Inc	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Primary	NULL
antiphosphotyrosine	NULL
antibody	NULL
(	NULL
sc-7020	NULL
;	NULL
1/1,000	NULL
dilution	NULL
;	NULL
Santa	NULL
Cruz	NULL
)	NULL
was	NULL
allowed	NULL
to	NULL
bind	NULL
in	NULL
PBS	NULL
containing	NULL
3	NULL
%	NULL
BSA	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
secondary	NULL
antibody	NULL
binding	NULL
with	NULL
Biotin-SP-conjugated	NULL
goat	NULL
antimouse	NULL
IgG	NULL
(	NULL
115-066-0772	NULL
;	NULL
1/10,000	NULL
dilution	NULL
;	NULL
Jack-son	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
this	NULL
,	NULL
peroxidase-conjugated	NULL
streptavidin	NULL
(	NULL
Jackson	NULL
)	NULL
was	NULL
allowed	NULL
to	NULL
bind	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
the	NULL
ECL	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
reprobed	NULL
with	NULL
anti-STAT1	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
anti-STAT3	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
anti-STAT4	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
,	NULL
anti-STAT5a	NULL
(	NULL
ZYMED	NULL
)	NULL
,	NULL
or	NULL
anti-STAT	NULL
5b	NULL
(	NULL
ZYMED	NULL
)	NULL
antibodies	NULL
in	NULL
PBS	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
for	NULL
2	NULL
hours	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
secondary	NULL
antibody	NULL
binding	NULL
with	NULL
peroxidase-conjugated	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
visualized	NULL
by	NULL
the	NULL
ECL	NULL
chemiluminescence	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

T-cell	NULL
proliferation	NULL
assay	NULL
.	NULL

-	NULL
Anti-CD3-activated	NULL
T	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
IL-2-containing	NULL
media	NULL
before	NULL
the	NULL
proliferation	NULL
assay	NULL
.	NULL

Cell	NULL
cultures	NULL
with	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
viability	NULL
were	NULL
used	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
%	NULL
10°	NULL
cells	NULL
(	NULL
10°	NULL
cells/mL	NULL
)	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
IFN-a	NULL
«	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
resuspended	NULL
into	NULL
IFN-free	NULL
RPMI	NULL
.	NULL

Fifty	NULL
microliters	NULL
of	NULL
cell	NULL
suspension	NULL
(	NULL
50,000	NULL
cells	NULL
)	NULL
was	NULL
seeded	NULL
in	NULL
triplicates	NULL
into	NULL
a	NULL
round-bottom	NULL
96-well	NULL
plate	NULL
(	NULL
Greiner	NULL
,	NULL
Niirtingen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

IL-2	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
0	NULL
,	NULL
10	NULL
,	NULL
30	NULL
,	NULL
or	NULL
100	NULL
IU/mL	NULL
.	NULL

After	NULL
thorough	NULL
mixing	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
37°C	NULL
for	NULL
18	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
another	NULL
6	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
uCi/well	NULL
of	NULL
``	NULL
H-labeled	NULL
thymidine	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
using	NULL
a	NULL
harvester	NULL
(	NULL
Tomtec	NULL
Harvester	NULL
96	NULL
Mach	NULL
IIIM	NULL
,	NULL
Tomtec	NULL
Inc	NULL
,	NULL
Hamden	NULL
,	NULL
CT	NULL
)	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
microplate	NULL
counter	NULL
(	NULL
Wallac	NULL
1450	NULL
Microbeta	NULL
Liquid	NULL
Scintillation	NULL
Counter	NULL
,	NULL
Wallac	NULL
,	NULL
Turku	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

The	NULL
proliferation	NULL
index	NULL
was	NULL
calculated	NULL
as	NULL
follows	NULL
:	NULL
index	NULL
=	NULL
(	NULL
IL-2	NULL
induced	NULL
incorporation	NULL
background	NULL
incorporation	NULL
)	NULL
/background	NULL
incorporation	NULL
.	NULL

RESULTS	NULL
IFN-	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
enhance	NULL
IL-2Ra	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
mRNA	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

-	NULL
IFN-a	NULL
is	NULL
an	NULL
important	NULL
T-cell	NULL
regulatory	NULL
cytokine	NULL
that	NULL
,	NULL
eg	NULL
,	NULL
enhances	NULL
T-cell	NULL
cytotoxicity	NULL
``	NULL
and	NULL
stimulates	NULL
T-cell	NULL
growth	NULL
.	NULL
``	NULL

We	NULL
therefore	NULL
studied	NULL
whether	NULL
IL-2Ra	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
,	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
proliferation	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
IL-2	NULL
are	NULL
also	NULL
upregulated	NULL
by	NULL
IFN-	NULL
«	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-1	NULL
5	NULL
.	NULL

We	NULL
used	NULL
activated	NULL
T	NULL
cells	NULL
to	NULL
ensure	NULL
that	NULL
the	NULL
cells	NULL
were	NULL
maximally	NULL
responsive	NULL
to	NULL
cytokine	NULL
treatment	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
or	NULL
IL-15	NULL
or	NULL
with	NULL
different	NULL
combinations	NULL
of	NULL
these	NULL
cytokines	NULL
.	NULL

After	NULL
3	NULL
hours	NULL
of	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1982	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
all	NULL
enhanced	NULL
IL-2Ra	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
mRNA	NULL
expression	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
were	NULL
certain	NULL
differences	NULL
between	NULL
the	NULL
cytokines	NULL
in	NULL
inducing	NULL
IL-2Re	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
genes	NULL
.	NULL

IL-2R	NULL
«	NULL
was	NULL
induced	NULL
by	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IL-15	NULL
,	NULL
whereas	NULL
only	NULL
a	NULL
weak	NULL
induction	NULL
was	NULL
seen	NULL
by	NULL
IL-12	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

IFEN-	NULL
@	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-1	NULL
5	NULL
all	NULL
induced	NULL
c-myc	NULL
and	NULL
pim-I	NULL
gene	NULL
expression	NULL
,	NULL
with	NULL
IL-12	NULL
having	NULL
the	NULL
strongest	NULL
and	NULL
IL-2	NULL
the	NULL
weakest	NULL
effect	NULL
.	NULL

IL-12	NULL
combined	NULL
with	NULL
IL-2	NULL
or	NULL
IL-15	NULL
most	NULL
strongly	NULL
enhanced	NULL
IL-2Ra	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IFN-e	NULL
combined	NULL
with	NULL
IL-2	NULL
or	NULL
IL-15	NULL
had	NULL
a	NULL
synergistic	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
all	NULL
genes	NULL
studied	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Because	NULL
IFN-	NULL
@	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
upregulated	NULL
IL-2Ra	NULL
mRNA	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
studied	NULL
IL-2Ra	NULL
«	NULL
protein	NULL
expression	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
hours	NULL
with	NULL
IFN-a	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
,	NULL
after	NULL
which	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
lysates	NULL
were	NULL
prepared	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1B	NULL
,	NULL
IL-2Ra	NULL
was	NULL
expressed	NULL
at	NULL
basal	NULL
level	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
mRNA	NULL
data	NULL
,	NULL
IL-15	NULL
A	NULL
Stimulation	NULL
(	NULL
3	NULL
h	NULL
)	NULL
MATIKAINEN	NULL
ET	NULL
AL	NULL
was	NULL
the	NULL
strongest	NULL
and	NULL
IL-12	NULL
the	NULL
weakest	NULL
inducer	NULL
of	NULL
IL-2Ra	NULL
«	NULL
protein	NULL
expression	NULL
.	NULL

Also	NULL
,	NULL
IFN-	NULL
«	NULL
and	NULL
IL-2	NULL
clearly	NULL
upregulated	NULL
IL-2Ra	NULL
«	NULL
protein	NULL
expression	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Because	NULL
IFN-	NULL
«	NULL
was	NULL
able	NULL
to	NULL
turn	NULL
on	NULL
genes	NULL
associated	NULL
with	NULL
T-cell	NULL
proliferation	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
study	NULL
the	NULL
dose-dependent	NULL
effect	NULL
of	NULL
IFN-a	NULL
«	NULL
and	NULL
IFN-	NULL
on	NULL
IL-2Ra	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
IFN-a	NULL
or	NULL
IFN-	NULL
.	NULL

Very	NULL
low	NULL
doses	NULL
(	NULL
1	NULL
IU/mL	NULL
)	NULL
of	NULL
IFN-a	NULL
and	NULL
IFN-	NULL
were	NULL
able	NULL
to	NULL
induce	NULL
IL-2R	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-	NULL
I	NULL
mRNA	NULL
expression	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
induction	NULL
takes	NULL
place	NULL
with	NULL
physiologically	NULL
relevant	NULL
IFN	NULL
concentrations	NULL
.	NULL

High	NULL
expression	NULL
levels	NULL
of	NULL
these	NULL
genes	NULL
were	NULL
detected	NULL
with	NULL
10	NULL
IU/mL	NULL
of	NULL
both	NULL
IFN-a	NULL
«	NULL
and	NULL
IFN-f.	NULL
IFN-a	NULL
priming	NULL
enhances	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Because	NULL
IFN-	NULL
«	NULL
was	NULL
able	NULL
to	NULL
enhance	NULL
IL-2Ra	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
studied	NULL
whether	NULL
IFN-a	NULL
«	NULL
pretreatment	NULL
would	NULL
sensitize	NULL
T	NULL
cells	NULL
to	NULL
IL-2-induced	NULL
cell	NULL
proliferation	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
pretreated	NULL
with	NULL
IFN-	NULL
«	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
restimulated	NULL
with	NULL
IL-2	NULL
,	NULL
and	NULL
the	NULL
T-cell	NULL
proliferation	NULL
was	NULL
analyzed	NULL
by	NULL
*H-labeled	NULL
thymidine	NULL
incorporation	NULL
assay	NULL
.	NULL

Proliferation	NULL
indexes	NULL
were	NULL
clearly	NULL
ou	NULL
No	NULL
mon	NULL
to	NULL
23	NULL
4	NULL
j	NULL
NP	NULL
m	NULL
-=	NULL
-	NULL
-	NULL
T	NULL
1	NULL
-=	NULL
to	NULL
t	NULL
t	NULL
=S	NULL
=	NULL
C	NULL
0	NULL
¢	NULL
«	NULL
u	NULL
m	NULL
P	NULL
P	NULL
P	NULL
i	NULL
+	NULL
a	NULL
o	NULL
5	NULL
z	NULL
YV	NULL
v	NULL
~	NULL
zZ	NULL
2	NULL
2	NULL
N	NULL
VN	NULL
~	NULL
§	NULL
2	NULL
l	NULL
uS	NULL
Jo	NULL
g_	NULL
W	NULL
l	NULL
l	NULL
-	NULL
3	NULL
-J	NULL
2	NULL
tho	NULL
#	NULL
>	NULL
Cai	NULL
Cen	NULL
-mm	NULL
thai	NULL
«	NULL
--	NULL
IL-2Ra	NULL
took	NULL
o	NULL
>	NULL
Sook	NULL
Salih	NULL
mae	NULL
Wh	NULL
=	NULL
--	NULL
too	NULL
___	NULL
bord	NULL
ao	NULL
tap	NULL
tnd	NULL
tnd	NULL
tnd	NULL
mn	NULL
tp	NULL
<	NULL
-	NULL
C-myC	NULL
hos	NULL
<	NULL
>	NULL
tat	NULL
tut	NULL
tnd	NULL
tnd	NULL
wes	NULL
tap	NULL
«	NULL
--	NULL
pim-1	NULL
Stimulation	NULL
(	NULL
24	NULL
h	NULL
)	NULL
o	NULL
3	NULL
aA	NULL
_	NULL
in	NULL
5	NULL
2	NULL
YV	NULL
t	NULL
T	NULL
2	NULL
U	NULL
S	NULL
S	NULL
sues	NULL
-	NULL
seme	NULL
.	NULL

amai	NULL
:	NULL
.	NULL

o	NULL
bag	NULL
wae	NULL
Hon	NULL
39	NULL
IL-2Ra	NULL
W|	NULL
«	NULL
--	NULL
188	NULL
rRNA	NULL
«	NULL
--	NULL
288	NULL
rRNA	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Induction	NULL
of	NULL
/L-2Me	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
by	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
cytokines	NULL
for	NULL
3	NULL
hours	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
the	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

RNA	NULL
samples	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
were	NULL
size-fractionated	NULL
on	NULL
agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
specific	NULL
L-2M	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
cDNA	NULL
probes	NULL
.	NULL

EtBr-stained	NULL
gel	NULL
is	NULL
shown	NULL
to	NULL
verify	NULL
equal	NULL
RNA	NULL
loading	NULL
.	NULL

The	NULL
result	NULL
shown	NULL
is	NULL
from	NULL
one	NULL
experiment	NULL
but	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
individual	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
IL-2R	NULL
«	NULL
protein	NULL
expression	NULL
by	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
1L-12	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
cytokines	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-IL-2Re	NULL
antibody	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

INF-	NULL
«	NULL
ACTIVATES	NULL
MULTIPLE	NULL
STAT	NULL
PROTEINS	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
higher	NULL
in	NULL
cells	NULL
compared	NULL
with	NULL
unprimed	NULL
ones	NULL
.	NULL

This	NULL
phenomenon	NULL
was	NULL
observed	NULL
with	NULL
all	NULL
IL-2	NULL
concentrations	NULL
tested	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Cytokine-induced	NULL
STAT	NULL
DNA-binding	NULL
to	NULL
the	NULL
IL-2Ra	NULL
GAS-c/	NULL
GAS-n	NULL
element	NULL
.	NULL

-	NULL
Many	NULL
cytokines	NULL
use	NULL
the	NULL
Jak/STAT	NULL
pathway	NULL
in	NULL
their	NULL
signaling	NULL
and	NULL
activate	NULL
genes	NULL
via	NULL
GAS	NULL
elements	NULL
.	NULL
'	NULL

''	NULL
``	NULL
Recently	NULL
,	NULL
an	NULL
essential	NULL
upstream	NULL
IL-2	NULL
response	NULL
element	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
was	NULL
characterized	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
a	NULL
consensus	NULL
and	NULL
a	NULL
nonconsensus	NULL
GAS	NULL
motif	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
IL-2-induced	NULL
IL-2Ra	NULL
gene	NULL
expression	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
To	NULL
characterize	NULL
the	NULL
proteins	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
GAS-c/GAS-n	NULL
element	NULL
(	NULL
-3778	NULL
to	NULL
-3740	NULL
)	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
,	NULL
we	NULL
stimulated	NULL
T	NULL
cells	NULL
with	NULL
different	NULL
cytokines	NULL
,	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
performed	NULL
EMSA	NULL
.	NULL

EMSAs	NULL
with	NULL
the	NULL
GAS-c/GAS-n	NULL
oligonucleotide	NULL
showed	NULL
the	NULL
induction	NULL
of	NULL
one	NULL
major	NULL
complex	NULL
in	NULL
response	NULL
to	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-15	NULL
stimulation	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
IL-2-	NULL
and	NULL
IL-15-induced	NULL
complexes	NULL
differed	NULL
from	NULL
the	NULL
ones	NULL
induced	NULL
by	NULL
IFN-	NULL
«	NULL
or	NULL
IL-12	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
1983	NULL
cytokines	NULL
activate	NULL
a	NULL
different	NULL
range	NULL
of	NULL
STAT	NULL
proteins	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
the	NULL
IFN-o-induced	NULL
complex	NULL
was	NULL
clearly	NULL
the	NULL
stron-gest	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
formed	NULL
already	NULL
at	NULL
0.5	NULL
hours	NULL
after	NULL
IFN-	NULL
«	NULL
stimulation	NULL
,	NULL
and	NULL
it	NULL
was	NULL
detectable	NULL
at	NULL
1	NULL
hour	NULL
after	NULL
stimulation	NULL
but	NULL
disappeared	NULL
thereafter	NULL
.	NULL

Similarly	NULL
,	NULL
IL-2-	NULL
,	NULL
IL-12-	NULL
,	NULL
and	NULL
IL-15-induced	NULL
complexes	NULL
were	NULL
detectable	NULL
only	NULL
at	NULL
0.5	NULL
hours	NULL
and	NULL
1	NULL
hour	NULL
after	NULL
stimulation	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
identified	NULL
the	NULL
proteins	NULL
within	NULL
these	NULL
complexes	NULL
using	NULL
specific	NULL
anti-STAT	NULL
antibodies	NULL
in	NULL
supershift	NULL
experiments	NULL
.	NULL

Antibodies	NULL
against	NULL
STAT1	NULL
almost	NULL
completely	NULL
abolished	NULL
IFN-	NULL
«	NULL
-induced	NULL
DNA	NULL
binding	NULL
to	NULL
GAS-c/GAS-n	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
anti-STAT3	NULL
and	NULL
anti-STAT4	NULL
antibodies	NULL
resulted	NULL
in	NULL
a	NULL
clearly	NULL
detectable	NULL
supershift	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
IFN-o-induced	NULL
complexes	NULL
consist	NULL
of	NULL
at	NULL
least	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
proteins	NULL
.	NULL

IL-12-induced	NULL
DNA	NULL
binding	NULL
complex	NULL
reacted	NULL
only	NULL
with	NULL
anti-STAT4	NULL
antibodies	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IL-2	NULL
and	NULL
IL-15	NULL
both	NULL
induced	NULL
STATS	NULL
DNA	NULL
binding	NULL
to	NULL
GAS-c/GAS-n	NULL
as	NULL
detected	NULL
by	NULL
supershift	NULL
experiments	NULL
(	NULL
Fig	NULL
4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Stimulation	NULL
(	NULL
3	NULL
h	NULL
)	NULL
_-	NULL
g	NULL
E	NULL
g	NULL
E53	NULL
>	NULL
D—	NULL
3	NULL
=	NULL
o	NULL
3	NULL
-	NULL
GO	NULL
O	NULL
O	NULL
o	NULL
$	NULL
3	NULL
$	NULL
P	NULL
5	NULL
Z	NULL
Z	NULL
zZ	NULL
Z	NULL
z	NULL
k	NULL
l	NULL
l	NULL
IFN-B	NULL
1	NULL
1VU/m	NULL
!	NULL

IFN-B	NULL
10	NULL
IU/ml	NULL
!	NULL

IFN-B	NULL
100	NULL
IU/ml	NULL
IFN-B	NULL
1000	NULL
IU/ml	NULL
None	NULL
Baculo	NULL
IFN-o1	NULL
«	NULL
--	NULL
IL-2Ra	NULL
1,1	NULL
<	NULL
woo	NULL
C	NULL
tat	NULL
ti	NULL
mn	NULL
an	NULL
ware	NULL
wee	NULL
-	NULL
wat	NULL
<	NULL
--	NULL
c-myc	NULL
‘	NULL
-~~	NULL
Fig	NULL
2	NULL
.	NULL

Dose-dependent	NULL
activation	NULL
of	NULL
IL-2RM	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
by	NULL
type	NULL
I	NULL
IFNs	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
different	NULL
doses	NULL
of	NULL
IFN-a	NULL
or	NULL
IFN-B	NULL
for	NULL
3	NULL
hours	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

RNA	NULL
samples	NULL
(	NULL
20	NULL
g	NULL
)	NULL
were	NULL
size-fractionated	NULL
on	NULL
agarose	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
IL-2Me	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
cDNA	NULL
probes	NULL
.	NULL

EtBr-stained	NULL
gel	NULL
is	NULL
shown	NULL
to	NULL
verify	NULL
equal	NULL
RNA	NULL
loading	NULL
.	NULL

wa	NULL
--	NULL
pim-1	NULL
``	NULL
H	NULL
``	NULL
”	NULL
H	NULL
``	NULL
H	NULL
<	NULL
--	NULL
28S	NULL
rRNA	NULL
acotatotasauuwt-ttac	NULL
``	NULL
<	NULL
--	NULL
188	NULL
rRNA	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1984	NULL
16	NULL
14	NULL
12	NULL
10	NULL
T	NULL
T-	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
Proliferation	NULL
index	NULL
Co	NULL
o	NULL
n	NULL
-A	NULL
o	NULL
TT	NULL
TT	NULL
TAI	NULL
adl	NULL
bes	NULL
IL-2	NULL
1U/m	NULL
!	NULL

Fig	NULL
3	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
IFN-a	NULL
pretreatment	NULL
on	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
activated	NULL
with	NULL
anti-CD3-antibodies	NULL
and	NULL
expanded	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
,	NULL
after	NULL
w	NULL
hich	NULL
IL-2-containing	NULL
medium	NULL
was	NULL
removed	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
100	NULL
IU/mL	NULL
of	NULL
IFN-	NULL
«	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
an	NULL
equal	NULL
number	NULL
of	NULL
(	NULL
C	NULL
)	NULL
)	NULL
untreated	NULL
or	NULL
(	NULL
MI	NULL
)	NULL
IFN-	NULL
«	NULL
-primed	NULL
T	NULL
cells	NULL
was	NULL
applied	NULL
in	NULL
microtiter	NULL
plates	NULL
.	NULL

Different	NULL
doses	NULL
of	NULL
IL-2	NULL
were	NULL
added	NULL
for	NULL
18	NULL
hours	NULL
,	NULL
followed	NULL
by	NULL
further	NULL
incubation	NULL
of	NULL
6	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
pCi/well	NULL
of	NULL
H-labeled	NULL
thymidine	NULL
.	NULL

After	NULL
harvesting	NULL
the	NULL
cells	NULL
,	NULL
the	NULL
proliferation	NULL
index	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
mean	NULL
proliferation	NULL
index	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
six	NULL
individual	NULL
donors	NULL
is	NULL
show	NULL
n.	NULL
IFN-a	NULL
induces	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
DNA	NULL
binding	NULL
to	NULL
IRF-1	NULL
and	NULL
pim-1	NULL
GAS	NULL
elements	NULL
.	NULL

Analysis	NULL
of	NULL
pim-1	NULL
gene	NULL
promoter	NULL
has	NULL
shown	NULL
a	NULL
functional	NULL
GAS	NULL
element	NULL
that	NULL
binds	NULL
STAT1	NULL
homodimer	NULL
in	NULL
response	NULL
to	NULL
IFN-y	NULL
stimulation	NULL
.	NULL
``	NULL

We	NULL
studied	NULL
STAT	NULL
binding	NULL
to	NULL
pim-1	NULL
GAS	NULL
in	NULL
T	NULL
lymphocytes	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

EMSA	NULL
indicated	NULL
that	NULL
several	NULL
STAT	NULL
complexes	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
pim-1	NULL
GAS	NULL
element	NULL
(	NULL
-934	NULL
to	NULL
-905	NULL
)	NULL
in	NULL
response	NULL
to	NULL
IFN-	NULL
«	NULL
stimulation	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
detectable	NULL
at	NULL
0.5	NULL
hours	NULL
after	NULL
IFN-	NULL
«	NULL
treatment	NULL
and	NULL
disappeared	NULL
within	NULL
3	NULL
hours	NULL
.	NULL

IL-12	NULL
induced	NULL
two	NULL
different	NULL
DNA	NULL
binding	NULL
complexes	NULL
when	NULL
pim-1	NULL
GAS	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

Both	NULL
IL-2	NULL
and	NULL
IL-15	NULL
induced	NULL
three	NULL
different	NULL
DNA	NULL
binding	NULL
complexes	NULL
.	NULL

Supershift	NULL
experiments	NULL
with	NULL
specific	NULL
anti-STAT	NULL
antibodies	NULL
indicated	NULL
that	NULL
IFN-	NULL
«	NULL
-induced	NULL
complexes	NULL
consisted	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
lower-most	NULL
complex	NULL
induced	NULL
by	NULL
IFN-	NULL
«	NULL
supershifted	NULL
with	NULL
anti-STAT1	NULL
antibody	NULL
only	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
complexes	NULL
that	NULL
supershifted	NULL
with	NULL
anti-STAT1	NULL
and/or	NULL
anti-STAT3	NULL
antibodies	NULL
suggested	NULL
that	NULL
STAT1-STAT3	NULL
heterodimers	NULL
and	NULL
STAT3	NULL
homodimers	NULL
were	NULL
formed	NULL
after	NULL
IFN-	NULL
«	NULL
stimulation	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
IL-12-induced	NULL
complex	NULL
was	NULL
comparable	NULL
to	NULL
the	NULL
uppermost	NULL
complex	NULL
seen	NULL
in	NULL
IFN-a	NULL
«	NULL
-treated	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
complexes	NULL
supershifted	NULL
with	NULL
anti-STAT4	NULL
antibodies	NULL
,	NULL
suggesting	NULL
that	NULL
IFN-a	NULL
«	NULL
is	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
STAT4	NULL
DNA	NULL
binding	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
uppermost	NULL
complex	NULL
was	NULL
also	NULL
supershifted	NULL
with	NULL
anti-STAT1	NULL
antibody	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
heterodimers	NULL
consisting	NULL
of	NULL
STAT1	NULL
and	NULL
STAT4	NULL
are	NULL
formed	NULL
in	NULL
response	NULL
to	NULL
IFN-	NULL
«	NULL
stimulation	NULL
.	NULL

Because	NULL
IRF-1	NULL
GAS	NULL
element	NULL
binds	NULL
STATs	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
,	NULL
albeit	NULL
with	NULL
different	NULL
strengths	NULL
,	NULL
``	NULL
``	NULL
we	NULL
wanted	NULL
to	NULL
analyze	NULL
the	NULL
T-cell-specific	NULL
STAT	NULL
binding	NULL
to	NULL
this	NULL
element	NULL
.	NULL

Again	NULL
,	NULL
IFN-	NULL
«	NULL
MATIKAINEN	NULL
ET	NULL
AL	NULL
induced	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
multiple	NULL
complexes	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

IFEN-a	NULL
«	NULL
induced	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
to	NULL
IRF-1	NULL
GAS	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

IFN-o-induced	NULL
STAT3	NULL
DNA	NULL
binding	NULL
to	NULL
IRF-1	NULL
GAS	NULL
was	NULL
very	NULL
weak	NULL
compared	NULL
with	NULL
STAT1	NULL
or	NULL
STAT4	NULL
DNA	NULL
binding	NULL
,	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
low	NULL
affinity	NULL
of	NULL
STAT3	NULL
to	NULL
IRF-1	NULL
GAS	NULL
.	NULL

IL-12	NULL
induced	NULL
two	NULL
complexes	NULL
,	NULL
of	NULL
which	NULL
the	NULL
upper	NULL
complex	NULL
supershifted	NULL
with	NULL
anti-STAT4	NULL
antibody	NULL
only	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Both	NULL
IL-2	NULL
and	NULL
IL-15	NULL
stimulation	NULL
resulted	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
only	NULL
one	NULL
major	NULL
DNA	NULL
binding	NULL
complex	NULL
that	NULL
was	NULL
detectable	NULL
at	NULL
least	NULL
up	NULL
to	NULL
6	NULL
hours	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
supershifted	NULL
with	NULL
anti-STATS5	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IFN-	NULL
enhances	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
STAT5a	NULL
,	NULL
and	NULL
STATS5b	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
anti-CD3-activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

-	NULL
Because	NULL
IFN-a	NULL
induced	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
DNA	NULL
binding	NULL
to	NULL
GAS	NULL
elements	NULL
,	NULL
we	NULL
also	NULL
analyzed	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
or	NULL
IL-12	NULL
,	NULL
STATs	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
antibodies	NULL
,	NULL
and	NULL
their	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
analyzed	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
.	NULL

In	NULL
unstimulated	NULL
cells	NULL
,	NULL
STAT1	NULL
and	NULL
STAT3	NULL
were	NULL
weakly	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
,	NULL
but	NULL
IFN-	NULL
«	NULL
strongly	NULL
enhanced	NULL
STAT1	NULL
and	NULL
STAT3	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

Both	NULL
IFN-	NULL
«	NULL
and	NULL
IL-12	NULL
strongly	NULL
enhanced	NULL
STAT4	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
of	NULL
detecting	NULL
antibody	NULL
and	NULL
reprobed	NULL
for	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
to	NULL
confirm	NULL
equal	NULL
loading	NULL
of	NULL
each	NULL
lane	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Because	NULL
it	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
IFN-a	NULL
«	NULL
activates	NULL
STAT	NULL
5a	NULL
in	NULL
promonocytic	NULL
U937	NULL
and	NULL
STAT	NULL
5b	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
we	NULL
wanted	NULL
to	NULL
study	NULL
whether	NULL
IFN-	NULL
«	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS5	NULL
also	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
or	NULL
IL-2	NULL
,	NULL
and	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
antiphosphotyrosine	NULL
immunoblotting	NULL
.	NULL

IFN-	NULL
«	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

IL-2	NULL
was	NULL
a	NULL
much	NULL
more	NULL
potent	NULL
in	NULL
inducing	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
tyrosine	NULL
phosphorylation	NULL
than	NULL
IFN-	NULL
«	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
reblotted	NULL
with	NULL
STAT5a	NULL
and	NULL
STATS5b	NULL
antibodies	NULL
to	NULL
determine	NULL
equal	NULL
loading	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
observed	NULL
IFN-o-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
,	NULL
we	NULL
were	NULL
not	NULL
able	NULL
to	NULL
detect	NULL
any	NULL
clear	NULL
STAT5	NULL
DNA	NULL
binding	NULL
to	NULL
IL-2Ra	NULL
,	NULL
pim-1	NULL
,	NULL
or	NULL
IRF-1	NULL
GAS	NULL
elements	NULL
.	NULL

To	NULL
further	NULL
analyze	NULL
whether	NULL
IFN-a	NULL
«	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
STAT5	NULL
DNA	NULL
binding	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
with	NULL
IFP53	NULL
GAS	NULL
element	NULL
that	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
STATS	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL
``	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
and	NULL
IL-2	NULL
for	NULL
0.5	NULL
hours	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
in	NULL
EMSA	NULL
.	NULL

IFN-a	NULL
«	NULL
induced	NULL
both	NULL
STAT1	NULL
and	NULL
STAT	NULL
5	NULL
DNA	NULL
binding	NULL
to	NULL
IFP53	NULL
GAS	NULL
,	NULL
whereas	NULL
IL-2	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
STATS	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

IFN-	NULL
priming	NULL
enhances	NULL
IL-2-induced	NULL
STAT1	NULL
and	NULL
STATS3	NULL
DNA	NULL
binding	NULL
.	NULL

Because	NULL
IFN-	NULL
priming	NULL
enhanced	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
we	NULL
studied	NULL
whether	NULL
IFN-	NULL
«	NULL
has	NULL
any	NULL
effect	NULL
on	NULL
IL-2-induced	NULL
STAT	NULL
DNA	NULL
binding	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
IFN-	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
IL-2	NULL
(	NULL
0	NULL
,	NULL
3	NULL
,	NULL
10	NULL
,	NULL
or	NULL
30	NULL
IU/mL	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

In	NULL
unprimed	NULL
T	NULL
cells	NULL
,	NULL
IL-2	NULL
induced	NULL
one	NULL
major	NULL
and	NULL
one	NULL
minor	NULL
IRF-1	NULL
GAS	NULL
binding	NULL
complex	NULL
.	NULL

In	NULL
IFN-o-primed	NULL
,	NULL
IL-2-stimulated	NULL
cells	NULL
,	NULL
IRF-1	NULL
GAS	NULL
DNA	NULL
binding	NULL
was	NULL
markedly	NULL
enhanced	NULL
.	NULL

The	NULL
upper	NULL
complex	NULL
supershifted	NULL
with	NULL
anti-STATS5	NULL
antibody	NULL
and	NULL
the	NULL
lower	NULL
complex	NULL
with	NULL
anti	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

INF-	NULL
«	NULL
ACTIVATES	NULL
MULTIPLE	NULL
STAT	NULL
PROTEINS	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
IL-12	NULL
IL-2	NULL
IFN-A	NULL
040.5	NULL
1	NULL
3	NULL
6	NULL
0.5	NULL
1	NULL
.n	NULL
on	NULL
B	NULL
-	NULL
o	NULL
IFN-a	NULL
0.	NULL
o	NULL
IL-2	NULL
0.5	NULL
h	NULL
1985	NULL
IL-15	NULL
o-lI	NULL
3	NULL
60.5	NULL
1	NULL
3	NULL
60.5	NULL
1	NULL
3	NULL
6	NULL
time/h	NULL
C	NULL
p	NULL
IL-12	NULL
0.5	NULL
h	NULL
p	NULL
IL-15	NULL
0.5	NULL
h	NULL
<	NULL
og	NULL
og	NULL
uz	NULL
t	NULL
g	NULL
g	NULL
in	NULL
5	NULL
5s	NULL
5	NULL
9	NULL
8	NULL
s	NULL
8	NULL
5	NULL
antibody	NULL
-	NULL
-	NULL
§	NULL
§	NULL
§	NULL
5	NULL
-	NULL
-	NULL
5	NULL
5	NULL
5	NULL
5	NULL
woe	NULL
ae	NULL
aos	NULL
.	NULL

ame	NULL
ggg	NULL
ae	NULL
»	NULL
.	NULL

Lind	NULL
we	NULL
anti-Stat1	NULL
anti-Stat3	NULL
anti-Stat1	NULL
*	NULL
anti-Stat	NULL
|	NULL
anti-Stat5|	NULL
O	NULL
<	NULL
%	NULL
ig	NULL
s	NULL
6	NULL
S	NULL
S	NULL
P	NULL
Q	NULL
$	NULL
o	NULL
#	NULL
C	NULL
C	NULL
6	NULL
6	NULL
antibody	NULL
-	NULL
-	NULL
}	NULL
.	NULL

anti-Stat4	NULL
&	NULL
r	NULL
€	NULL
J	NULL
b*	NULL
-	NULL
batata	NULL
)	NULL
Fig	NULL
4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
STAT	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
/L-2R	NULL
«	NULL
GAS-c/	NULL
GAS-n	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-a	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
or	NULL
IL-15	NULL
as	NULL
indicated	NULL
;	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
cells	NULL
;	NULL
and	NULL
the	NULL
STAT	NULL
DNA	NULL
binding	NULL
w	NULL
as	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
STAT	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
IL-2R	NULL
«	NULL
GAS-c/	NULL
GAS-n	NULL
in	NULL
response	NULL
to	NULL
IFN-	NULL
«	NULL
and	NULL
IL-2	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
or	NULL
IL-2	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
after	NULL
which	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
with	NULL
STAT	NULL
antibodies	NULL
indicated	NULL
,	NULL
followed	NULL
by	NULL
binding	NULL
to	NULL
*°P-labeled	NULL
/L-2Re	NULL
.	NULL

GAS-c/	NULL
GAS-n	NULL
probe	NULL
.	NULL

(	NULL
C	NULL
)	NULL
STAT	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
/-2Ra	NULL
GAS-c/GAS-n	NULL
in	NULL
response	NULL
to	NULL
IL-12	NULL
and	NULL
IL-15	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
or	NULL
IL-15	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
with	NULL
different	NULL
anti-STAT	NULL
antibodies	NULL
followed	NULL
by	NULL
binding	NULL
to	NULL
``	NULL
P-labeled	NULL
{	NULL
L-2R	NULL
«	NULL
GAS-c/	NULL
GAS-n	NULL
probe	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

STAT1	NULL
antibody	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
IL-2	NULL
can	NULL
activate	NULL
STAT1	NULL
and	NULL
that	NULL
the	NULL
IFN-o	NULL
pretreatment	NULL
strongly	NULL
enhances	NULL
IL-2-induced	NULL
STAT	NULL
1	NULL
(	NULL
and	NULL
STAT5	NULL
)	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

Enhanced	NULL
STAT1	NULL
and	NULL
STATS	NULL
complex	NULL
formation	NULL
in	NULL
primed	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
stimulation	NULL
was	NULL
also	NULL
detected	NULL
when	NULL
pim-1	NULL
GAS	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-	NULL
«	NULL
did	NULL
not	NULL
enhance	NULL
IL-2-induced	NULL
STAT5	NULL
DNA	NULL
binding	NULL
to	NULL
IL-2R	NULL
«	NULL
GAS-c/GAS-n	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
gene	NULL
knock-out	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
functional	NULL
IFN-	NULL
«	NULL
/B	NULL
system	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
clearance	NULL
of	NULL
viral	NULL
infec-tion	NULL
.	NULL

*	NULL
``	NULL
``	NULL
``	NULL
It	NULL
is	NULL
also	NULL
well	NULL
accepted	NULL
that	NULL
IFN-a	NULL
«	NULL
can	NULL
directly	NULL
inhibit	NULL
proliferation	NULL
of	NULL
normal	NULL
and	NULL
tumor	NULL
cells	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL
``	NULL

However	NULL
,	NULL
there	NULL
is	NULL
some	NULL
evidence	NULL
that	NULL
IFN-	NULL
«	NULL
would	NULL
enhance	NULL
T-cell	NULL
growth	NULL
.	NULL

Tough	NULL
et	NULL
al	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
IFN-o-stimulated	NULL
CD8	NULL
*	NULL
cells	NULL
proliferate	NULL
and	NULL
survive	NULL
in	NULL
vivo	NULL
for	NULL
longer	NULL
periods	NULL
of	NULL
time	NULL
than	NULL
their	NULL
unstimulated	NULL
counterparts	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IFN-	NULL
«	NULL
priming	NULL
can	NULL
augment	NULL
IL-2-induced	NULL
human	NULL
T-cell	NULL
proliferation	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
this	NULL
phenomenon	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
IL-2Ra	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
gene	NULL
expression	NULL
.	NULL

Especially	NULL
,	NULL
IFN-o-induced	NULL
upregulation	NULL
of	NULL
IL-2Ra	NULL
expression	NULL
could	NULL
directly	NULL
contribute	NULL
to	NULL
enhanced	NULL
responsiveness	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
IL-2	NULL
.	NULL

Enhanced	NULL
pim-1	NULL
gene	NULL
expression	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
increased	NULL
T-cell	NULL
survival	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
that	NULL
overexpression	NULL
of	NULL
pim-1	NULL
can	NULL
accelerate	NULL
lymphoproliferation	NULL
by	NULL
inhibiting	NULL
Recent	NULL
results	NULL
from	NULL
studies	NULL
on	NULL
cytokine-mediated	NULL
signaling	NULL
suggest	NULL
that	NULL
pim-1	NULL
expression	NULL
correlates	NULL
with	NULL
the	NULL
viability	NULL
,	NULL
but	NULL
not	NULL
with	NULL
the	NULL
proliferation	NULL
potential	NULL
of	NULL
the	NULL
cells.4	NULL
>	NULL
3	NULL
Not	NULL
only	NULL
IFN-	NULL
«	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
also	NULL
IL-12	NULL
and	NULL
IL-15	NULL
as	NULL
well	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
anti-CD3-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Induction	NULL
of	NULL
IL-2Ra	NULL
gene	NULL
expression	NULL
by	NULL
IL-15	NULL
was	NULL
expected	NULL
,	NULL
because	NULL
IL-15	NULL
also	NULL
activates	NULL
STATS	NULL
and	NULL
uses	NULL
B	NULL
and	NULL
y	NULL
chains	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
during	NULL
downstream	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1986	NULL
A	NULL
IEN-o	NULL
.	NULL

O-	NULL
!	NULL

g35	NULL
IL-12	NULL
IL-2	NULL
id	NULL
IFN-a	NULL
0.5	NULL
h	NULL
©	NULL
a	NULL
©	NULL
N	NULL
O	NULL
<	NULL
U	NULL
U	NULL
)	NULL
©	NULL
sat	NULL
get	NULL
pdt	NULL
pt	NULL
pt	NULL
ued	NULL
ged	NULL
©	NULL
@	NULL
S8	NULL
6	NULL
@	NULL
©	NULL
G	NULL
sind	NULL
0	NULL
spt	NULL
shed	NULL
chet	NULL
0	NULL
deal	NULL
pst	NULL
P	NULL
Q	NULL
Q	NULL
Q	NULL
Q	NULL
o	NULL
o	NULL
€	NULL
C	NULL
C	NULL
C	NULL
C	NULL
C	NULL
C	NULL
*~	NULL
*~	NULL
0	NULL
G	NULL
G	NULL
G	NULL
6	NULL
G6	NULL
®	NULL
£	NULL
Csr	NULL
#	NULL
``	NULL
lims	NULL
&	NULL
#	NULL
#	NULL
=	NULL
4	NULL
%	NULL
a	NULL
Ovni	NULL
tnat	NULL
lits	NULL
iil	NULL
shes	NULL
.	NULL

.	NULL

Anat	NULL
signaling	NULL
.	NULL
``	NULL

However	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
IFN-	NULL
«	NULL
and	NULL
IL-12	NULL
induced	NULL
the	NULL
upregulation	NULL
of	NULL
ZL-2Ra	NULL
«	NULL
gene	NULL
expression	NULL
was	NULL
more	NULL
surpris-ing	NULL
.	NULL

An	NULL
IL-2-responsive	NULL
element	NULL
in	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
promoter	NULL
has	NULL
recently	NULL
been	NULL
characterized	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
This	NULL
element	NULL
binds	NULL
at	NULL
least	NULL
STAT5	NULL
,	NULL
Elf-1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
GATA	NULL
family	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
STATS	NULL
binding	NULL
site	NULL
consists	NULL
of	NULL
two	NULL
adjacent	NULL
GAS	NULL
elements	NULL
,	NULL
a	NULL
consensus	NULL
GAS	NULL
(	NULL
GAS-c	NULL
)	NULL
and	NULL
a	NULL
nonconsensus	NULL
one	NULL
(	NULL
GAS-n	NULL
)	NULL
,	NULL
which	NULL
are	NULL
well-conserved	NULL
in	NULL
human	NULL
and	NULL
mouse	NULL
promoters	NULL
.	NULL

Single	NULL
GAS	NULL
elements	NULL
of	NULL
ZIL-2Ra	NULL
promoter	NULL
appear	NULL
to	NULL
function	NULL
only	NULL
as	NULL
low-affinity	NULL
STATS	NULL
binding	NULL
sites	NULL
and	NULL
therefore	NULL
both	NULL
of	NULL
these	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
IL-2-induced	NULL
STATS	NULL
binding	NULL
.	NULL
``	NULL

Previously	NULL
,	NULL
cooperative	NULL
binding	NULL
of	NULL
STAT	NULL
complexes	NULL
to	NULL
weak	NULL
STAT	NULL
binding	NULL
sites	NULL
has	NULL
been	NULL
observed	NULL
,	NULL
eg	NULL
,	NULL
in	NULL
the	NULL
first	NULL
intron	NULL
of	NULL
IFN-y*	NULL
gene	NULL
and	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
mig	NULL
chemokine	NULL
Hb	NULL
-	NULL
antibody	NULL
MATIKAINEN	NULL
ET	NULL
AL	NULL
IL-15	NULL
1	NULL
3	NULL
605	NULL
|i	NULL
3	NULL
6	NULL
05	NULL
1	NULL
3	NULL
6	NULL
05	NULL
i	NULL
3	NULL
6°	NULL
time	NULL
O-II	NULL
Fig	NULL
5	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Multiple	NULL
STAT	NULL
complexes	NULL
bind	NULL
to	NULL
the	NULL
pim-1	NULL
GAS	NULL
element	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
or	NULL
IL-15	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
cells	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
P-labeled	NULL
pim-1	NULL
GAS	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
STAT	NULL
DNA	NULL
binding	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IFN-	NULL
«	NULL
induced	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
DNA	NULL
binding	NULL
to	NULL
pim-1	NULL
GAS	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
with	NULL
anti-STAT	NULL
antibodies	NULL
,	NULL
followed	NULL
by	NULL
binding	NULL
to	NULL
**P-labeled	NULL
pim-1	NULL
GAS	NULL
probe	NULL
.	NULL

Comparable	NULL
data	NULL
were	NULL
obtained	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
each	NULL
consisting	NULL
of	NULL
pooled	NULL
T	NULL
cells	NULL
from	NULL
two	NULL
different	NULL
do-nors	NULL
.	NULL

gene	NULL
.	NULL
``	NULL

''	NULL
In	NULL
our	NULL
experiments	NULL
,	NULL
by	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
cytokine-stimulated	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
not	NULL
only	NULL
IL-2-	NULL
and	NULL
IL-15-induced	NULL
STATS5	NULL
binding	NULL
,	NULL
but	NULL
also	NULL
IL-12-induced	NULL
STAT4	NULL
binding	NULL
to	NULL
the	NULL
IL-2Ra	NULL
«	NULL
GAS-c/GAS-n	NULL
element	NULL
.	NULL

More	NULL
interestingly	NULL
,	NULL
the	NULL
IFN-o-induced	NULL
complexes	NULL
consisted	NULL
of	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
proteins	NULL
,	NULL
suggesting	NULL
similar	NULL
cooperative	NULL
STAT	NULL
binding	NULL
mechanisms	NULL
as	NULL
described	NULL
for	NULL
the	NULL
other	NULL
genes	NULL
mentioned	NULL
above	NULL
.	NULL
``	NULL

''	NULL
The	NULL
expression	NULL
of	NULL
c-myc	NULL
and	NULL
pim-1	NULL
genes	NULL
was	NULL
induced	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
by	NULL
IL-2	NULL
,	NULL
which	NULL
is	NULL
the	NULL
primary	NULL
growth	NULL
factor	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
both	NULL
IFN-	NULL
«	NULL
and	NULL
IL-12	NULL
were	NULL
able	NULL
to	NULL
upregulate	NULL
the	NULL
expression	NULL
of	NULL
c-myc	NULL
and	NULL
pim-	NULL
]	NULL
genes	NULL
in	NULL
anti-CD3-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

pim-1	NULL
gene	NULL
promoter	NULL
contains	NULL
a	NULL
functional	NULL
GAS	NULL
element	NULL
.	NULL
``	NULL

''	NULL
It	NULL
is	NULL
also	NULL
presumable	NULL
that	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

INF-	NULL
«	NULL
ACTIVATES	NULL
MULTIPLE	NULL
STAT	NULL
PROTEINS	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
A	NULL
IFN-o	NULL
.	NULL

IL-	NULL
1987	NULL
12	NULL
IL-2	NULL
IL-15	NULL
9	NULL
!	NULL

g5	NULL
7	NULL
3	NULL
6	NULL
0.5	NULL
1	NULL
3	NULL
6	NULL
05	NULL
i	NULL
3	NULL
6	NULL
05	NULL
1	NULL
3	NULL
6°	NULL
)	NULL
!	NULL

time	NULL
Fig	NULL
6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
STAT	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
GAS	NULL
by	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
or	NULL
IL-15	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
,	NULL
IL-2	NULL
,	NULL
IL-12	NULL
,	NULL
or	NULL
IL-15	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
``	NULL
°P-labeled	NULL
/RF-1	NULL
GAS	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IFN-	NULL
«	NULL
-induced	NULL
STATA	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STATA	NULL
DNA	NULL
binding	NULL
to	NULL
IRF-1	NULL
GAS	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
with	NULL
anti-STAT	NULL
antibodies	NULL
,	NULL
followed	NULL
by	NULL
binding	NULL
to	NULL
P-labeled	NULL
IRF-1	NULL
GAS	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

toss	NULL
IFN-	NULL
«	NULL
-	NULL
and	NULL
IL-12-activated	NULL
STAT	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
upregulation	NULL
of	NULL
pim-	NULL
I	NULL
gene	NULL
expression	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
IFN-	NULL
«	NULL
induced	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STAT4	NULL
DNA	NULL
binding	NULL
to	NULL
pim-1	NULL
GAS	NULL
.	NULL

Similarly	NULL
,	NULL
IL-12	NULL
induced	NULL
STAT4	NULL
binding	NULL
to	NULL
GAS	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-12	NULL
upregulates	NULL
c-myc	NULL
gene	NULL
expression	NULL
in	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
It	NULL
is	NULL
also	NULL
known	NULL
that	NULL
Jak3	NULL
tyrosine	NULL
kinase	NULL
is	NULL
essential	NULL
for	NULL
IL-2-induced	NULL
expression	NULL
of	NULL
c-myc	NULL
gene	NULL
,	NULL
``	NULL
``	NULL
but	NULL
there	NULL
is	NULL
little	NULL
information	NULL
about	NULL
downstream	NULL
signal	NULL
transducing	NULL
molecules	NULL
and	NULL
no	NULL
evidence	NULL
of	NULL
STAT	NULL
protein	NULL
involvement	NULL
.	NULL

Further	NULL
analyses	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
IFN-o-	NULL
,	NULL
IL-2-	NULL
,	NULL
and	NULL
IL-12-induced	NULL
c-myc	NULL
gene	NULL
expression	NULL
are	NULL
clearly	NULL
needed	NULL
.	NULL

Previously	NULL
,	NULL
IFN-	NULL
«	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
able	NULL
to	NULL
specifically	NULL
activate	NULL
IFN-stimulated	NULL
gene	NULL
factor	NULL
complex	NULL
(	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
and	NULL
p48	NULL
heterotrimer	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Our	NULL
results	NULL
suggest	NULL
that	NULL
IFN-	NULL
«	NULL
can	NULL
also	NULL
induce	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
STATS	NULL
to	NULL
the	NULL
Tq	NULL
anti-Stat1	NULL
#	NULL
FN-	NULL
«	NULL
0.5	NULL
h	NULL
OG	NULL
o	NULL
9	NULL
S	NULL
2	NULL
2	NULL
92	NULL
S	NULL
S	NULL
S8	NULL
S8	NULL
S	NULL
S	NULL
®	NULL
4	NULL
5	NULL
4	NULL
6	NULL
5	NULL
s	NULL
5	NULL
&	NULL
5	NULL
5	NULL
§	NULL
-	NULL
antibody	NULL
n	NULL
”	NULL
A	NULL
.	NULL

K	NULL
}	NULL
#	NULL
bu	NULL
to	NULL
us	NULL
us	NULL
as	NULL
o	NULL
_	NULL
wt	NULL
w	NULL
#	NULL
specific	NULL
GAS	NULL
elements	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

IFN-o-induced	NULL
STAT3	NULL
activation	NULL
takes	NULL
place	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
``	NULL
``	NULL
``	NULL
'	NULL
and	NULL
this	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
be	NULL
due	NULL
to	NULL
a	NULL
direct	NULL
phosphotyrosine-dependent	NULL
interaction	NULL
between	NULL
IFNAR-1	NULL
and	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
STAT3	NULL
.	NULL
``	NULL

Whether	NULL
similar	NULL
interactions	NULL
between	NULL
STAT4	NULL
or	NULL
STATS	NULL
with	NULL
the	NULL
type	NULL
I	NULL
IFN	NULL
receptor	NULL
exist	NULL
remains	NULL
to	NULL
be	NULL
studied	NULL
.	NULL

Previously	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
both	NULL
IL-12	NULL
and	NULL
IFN-	NULL
«	NULL
were	NULL
able	NULL
to	NULL
activate	NULL
DNA	NULL
binding	NULL
of	NULL
STAT4	NULL
to	NULL
FeyRIZ	NULL
GAS	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL
``	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
clearly	NULL
demonstrate	NULL
that	NULL
in	NULL
our	NULL
T-cell	NULL
system	NULL
both	NULL
IFN-	NULL
«	NULL
and	NULL
IL-12	NULL
can	NULL
induce	NULL
STAT4	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
binding	NULL
of	NULL
STAT4	NULL
to	NULL
IRF-1	NULL
and	NULL
pim-1	NULL
GAS	NULL
elements	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
Northern	NULL
blot	NULL
data	NULL
that	NULL
demonstrated	NULL
that	NULL
pim-I	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
as	NULL
well	NULL
as	NULL
IRF-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
genes	NULL
were	NULL
upregulated	NULL
by	NULL
IFN-and	NULL
IL-12	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
IFN-	NULL
«	NULL
enhanced	NULL
tyrosine	NULL
phosphoryla-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1988	NULL
A	NULL
Antibody	NULL
Stimulation	NULL
e	NULL
$	NULL
a	NULL
ip	NULL
_	NULL
Bot	NULL
_	NULL
g	NULL
£	NULL
3	NULL
P-¥	NULL
-	NULL
<	NULL
-	NULL
STAT1	NULL
STAT	NULL
we	NULL
wis	NULL
)	NULL
wow	NULL
stam	NULL
.	NULL

.	NULL

-	NULL
stam	NULL
P-¥	NULL
l	NULL
<	NULL
-	NULL
STAT3	NULL
STAT3	NULL
ce	NULL
we	NULL
all	NULL
>	NULL
STAT3	NULL
-	NULL
@	NULL
ﬂ	NULL
WB	NULL
<	NULL
--	NULL
STAT3	NULL
P-¥	NULL
s	NULL
<	NULL
-	NULL
STATA	NULL
STATA	NULL
|STAT4	NULL
=	NULL
«	NULL
==	NULL
som	NULL
seg	NULL
<	NULL
-	NULL
STAT4	NULL
MATIKAINEN	NULL
ET	NULL
AL	NULL
B	NULL
Antibody	NULL
Stimulation	NULL
o	NULL
3	NULL
C	NULL
bo	NULL
o	NULL
ip	NULL
_	NULL
Blot	NULL
$	NULL
&	NULL
J	NULL
P-¥	NULL
|	NULL
eeeee	NULL
...	NULL
<	NULL
--	NULL
-	NULL
STATS5a	NULL
STATS5a	NULL
«	NULL
hemes	NULL
-	NULL
squee	NULL
-	NULL
Shish	NULL
|staTse	NULL
Wi	NULL
emp	NULL
gg	NULL
-	NULL
stats	NULL
P-Y¥	NULL
wouee	NULL
@	NULL
@	NULL
®	NULL
.	NULL

«	NULL
--	NULL
STAT5b	NULL
STATS5b	NULL
wease	NULL
|	NULL
cuere	NULL
|	NULL
wows	NULL
|STATSb	NULL
|	NULL
wth	NULL
emm	NULL
«	NULL
m	NULL
-	NULL
<	NULL
--	NULL
STATS5b	NULL
Fig	NULL
7	NULL
.	NULL

-	NULL
(	NULL
A	NULL
)	NULL
IFN-a	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
and	NULL
STAT4	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-a	NULL
«	NULL
or	NULL
IL-12	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
and	NULL
T-cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT1	NULL
,	NULL
anti-STAT3	NULL
,	NULL
or	NULL
anti-STAT4	NULL
antibodies	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
membranes	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT	NULL
antibodies	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IFN-	NULL
«	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATSa	NULL
and	NULL
STAT5b	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-a	NULL
«	NULL
or	NULL
IL-2	NULL
for	NULL
15	NULL
minutes	NULL
and	NULL
T-cell	NULL
lysates	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT5a	NULL
or	NULL
anti-STAT5b	NULL
antibodies	NULL
,	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-STAT	NULL
antibodies	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

tion	NULL
of	NULL
STAT	NULL
5a	NULL
and	NULL
STAT	NULL
5b	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
previously	NULL
shown	NULL
that	NULL
IFN-	NULL
«	NULL
selectively	NULL
enhances	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
of	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
respectively	NULL
,	NULL
although	NULL
both	NULL
cell	NULL
types	NULL
are	NULL
able	NULL
to	NULL
0	NULL
_	NULL
IFN-a	NULL
_	NULL
IL-2	NULL
anti-Stat1	NULL
anti-Stat5	NULL
anti-Stat1	NULL
anti-Stat5	NULL
antibody	NULL
-	NULL
express	NULL
STAT	NULL
5a	NULL
and	NULL
STAT5b	NULL
.	NULL
``	NULL

''	NULL
This	NULL
suggests	NULL
that	NULL
cell-type-specific	NULL
mechanisms	NULL
regulate	NULL
IFN-o-induced	NULL
activation	NULL
of	NULL
different	NULL
STATS	NULL
isoforms	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
,	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
IFN-	NULL
«	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
<	NULL
--	NULL
supershift	NULL
wo	NULL
®	NULL
1-4	NULL
<	NULL
--	NULL
STATS	NULL
«	NULL
--	NULL
STAT1	NULL
Fig	NULL
8	NULL
.	NULL

IFN-a-induced	NULL
STATS	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
IFP53	NULL
GAS	NULL
element	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IFN-	NULL
«	NULL
or	NULL
IL-2	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
incubated	NULL
with	NULL
anti-STAT1	NULL
or	NULL
anti-STAT5	NULL
antibodies	NULL
for	NULL
1	NULL
hour	NULL
on	NULL
ice	NULL
,	NULL
followed	NULL
by	NULL
EMSA	NULL
with	NULL
/FP53	NULL
GAS	NULL
probe	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

INF-	NULL
«	NULL
ACTIVATES	NULL
MULTIPLE	NULL
STAT	NULL
PROTEINS	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
1989	NULL
IFN-	NULL
priming	NULL
0	NULL
3	NULL
10	NULL
30	NULL
0	NULL
3	NULL
10	NULL
30	NULL
10	NULL
1010	NULL
IL-2	NULL
induction	NULL
(	NULL
IU/ml	NULL
)	NULL
Fig	NULL
9	NULL
.	NULL

IFN-	NULL
«	NULL
enhances	NULL
IL-2-induced	NULL
STAT1	NULL
and	NULL
STATS	NULL
binding	NULL
to	NULL
the	NULL
/RF-1	NULL
GAS	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
IFN-	NULL
«	NULL
(	NULL
100	NULL
IU/mL	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
fresh	NULL
medium	NULL
,	NULL
and	NULL
different	NULL
concentrations	NULL
of	NULL
IL-2	NULL
(	NULL
0	NULL
,	NULL
6	NULL
t	NULL
4	NULL
b	NULL
#	NULL
44	NULL
#	NULL
#	NULL
i	NULL
<	NULL
--	NULL
Stato	NULL
Be	NULL
iw	NULL
#	NULL
B	NULL
<	NULL
--	NULL
Stati	NULL
ls	NULL
as	NULL
i-	NULL
as	NULL
usie	NULL
as	NULL
6d	NULL
ts	NULL
ts	NULL
ad	NULL
3	NULL
,	NULL
10	NULL
,	NULL
or	NULL
30	NULL
IU/mL	NULL
)	NULL
were	NULL
added	NULL
.	NULL

After	NULL
30	NULL
minutes	NULL
of	NULL
incubation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
in	NULL
EMSA	NULL
with	NULL
IRF-1	NULL
GAS	NULL
probe	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
three	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

-	NULL
-	NULL
-_	NULL
anti-Stat1	NULL
f	NULL
_	NULL
None	NULL
-	NULL
o+o-	NULL
-	NULL
anti-Stat3	NULL
f	NULL
‘	NULL
nt'EOdyt	NULL
_-	NULL
_	NULL
--	NULL
-	NULL
anti-Stafs|	NULL
Teamen	NULL
STAT5a	NULL
and	NULL
STAT5b	NULL
.	NULL

IFN-o-induced	NULL
STATS5a	NULL
and	NULL
STAT5b	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
much	NULL
weaker	NULL
compared	NULL
with	NULL
IL-2	NULL
induction	NULL
,	NULL
and	NULL
no	NULL
clear	NULL
IFN-	NULL
«	NULL
-induced	NULL
STAT5	NULL
DNA	NULL
binding	NULL
to	NULL
IRF-1	NULL
,	NULL
pim-1	NULL
,	NULL
or	NULL
IL-2Roe	NULL
GAS	NULL
elements	NULL
was	NULL
detected	NULL
.	NULL

However	NULL
,	NULL
IFN-	NULL
«	NULL
induced	NULL
STAT5	NULL
DNA	NULL
binding	NULL
to	NULL
IFP53	NULL
GAS	NULL
element	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
bind	NULL
STATS	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL
``	NULL

''	NULL
This	NULL
may	NULL
suggest	NULL
that	NULL
IFN-	NULL
«	NULL
-induced	NULL
STATS	NULL
activation	NULL
has	NULL
physiological	NULL
significance	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
genes	NULL
that	NULL
contain	NULL
high-affinity	NULL
STATS	NULL
binding	NULL
sites	NULL
.	NULL

Because	NULL
IFN-	NULL
«	NULL
was	NULL
able	NULL
to	NULL
enhance	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
expression	NULL
and	NULL
T-cell	NULL
proliferation	NULL
,	NULL
we	NULL
studied	NULL
the	NULL
role	NULL
of	NULL
IFN-	NULL
«	NULL
in	NULL
IL-2-induced	NULL
STAT	NULL
activation	NULL
.	NULL

Pretreatment	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
IFN-	NULL
«	NULL
resulted	NULL
in	NULL
a	NULL
twofold	NULL
to	NULL
threefold	NULL
increase	NULL
in	NULL
IL-2-induced	NULL
STAT5	NULL
DNA	NULL
binding	NULL
,	NULL
which	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
enhanced	NULL
T-cell	NULL
proliferation	NULL
.	NULL

In	NULL
IFN-o-pretreated	NULL
T	NULL
cells	NULL
,	NULL
IL-2-induced	NULL
STAT1	NULL
DNA	NULL
binding	NULL
was	NULL
strongly	NULL
enhanced	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

This	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
upregulation	NULL
of	NULL
intracellular	NULL
STAT1	NULL
levels	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
to	NULL
enhanced	NULL
IL-2-induced	NULL
signaling	NULL
in	NULL
IFN-	NULL
«	NULL
pretreated	NULL
cells	NULL
.	NULL

The	NULL
former	NULL
possibility	NULL
may	NULL
be	NULL
the	NULL
more	NULL
likely	NULL
one	NULL
,	NULL
because	NULL
IFN-	NULL
«	NULL
strongly	NULL
enhances	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
and	NULL
p48	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
in	NULL
human	NULL
macrophages	NULL
``	NULL
as	NULL
well	NULL
as	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
STAT	NULL
1	NULL
was	NULL
expressed	NULL
in	NULL
relatively	NULL
high	NULL
levels	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
mechanisms	NULL
,	NULL
such	NULL
as	NULL
STAT1	NULL
tyrosine	NULL
or	NULL
serine/threonine	NULL
phosphorylation	NULL
by	NULL
IFN-	NULL
«	NULL
,	NULL
may	NULL
also	NULL
explain	NULL
enhanced	NULL
IL-2-induced	NULL
STAT1	NULL
DNA	NULL
binding	NULL
in	NULL
IFN-o-primed	NULL
T	NULL
cells	NULL
.	NULL

IFN-	NULL
«	NULL
was	NULL
first	NULL
described	NULL
as	NULL
a	NULL
substance	NULL
inhibiting	NULL
virus	NULL
growth	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL
``	NULL

Thereafter	NULL
,	NULL
much	NULL
of	NULL
the	NULL
research	NULL
work	NULL
focused	NULL
on	NULL
the	NULL
antiviral	NULL
and	NULL
antiproliferative	NULL
properties	NULL
of	NULL
IFN-	NULL
«	NULL
,	NULL
and	NULL
its	NULL
role	NULL
as	NULL
an	NULL
important	NULL
T-cell	NULL
regulatory	NULL
molecule	NULL
was	NULL
neglected	NULL
.	NULL
``	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
IFN-	NULL
«	NULL
/fB	NULL
is	NULL
able	NULL
to	NULL
activate	NULL
the	NULL
expression	NULL
of	NULL
ZL-2R	NULL
«	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
genes	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
T-cell	NULL
proliferation	NULL
or	NULL
survival	NULL
.	NULL

Pretreatment	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
with	NULL
also	NULL
enhanced	NULL
IL-2-induced	NULL
T-cell	NULL
proliferation	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
IFN-	NULL
«	NULL
is	NULL
rather	NULL
growth	NULL
stimulatory	NULL
than	NULL
inhibitory	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
IFN-	NULL
«	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
STAT4	NULL
and	NULL
STAT5	NULL
,	NULL
the	NULL
signaling	NULL
molecules	NULL
used	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
further	NULL
emphasizes	NULL
the	NULL
role	NULL
of	NULL
IFN-	NULL
@	NULL
/B	NULL
as	NULL
important	NULL
molecules	NULL
in	NULL
T-cell	NULL
biology	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
are	NULL
grateful	NULL
to	NULL
Dr	NULL
Hannele	NULL
T	NULL
&	NULL
lG	NULL
for	NULL
the	NULL
IFN-	NULL
«	NULL
and	NULL
Dr	NULL
Matti	NULL
Kaartinen	NULL
for	NULL
the	NULL
anti-CD3	NULL
antibodies	NULL
and	NULL
to	NULL
Marika	NULL
Ylisel4	NULL
,	NULL
Mari	NULL
Tapaninen	NULL
,	NULL
and	NULL
Valma	NULL
Mikinen	NULL
for	NULL
their	NULL
expert	NULL
technical	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Sen	NULL
GC	NULL
,	NULL
Ransohoff	NULL
RM	NULL
:	NULL
Interferon-induced	NULL
antiviral	NULL
actions	NULL
and	NULL
their	NULL
regulation	NULL
.	NULL

Adv	NULL
Virus	NULL
Res	NULL
42:57	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Belardelli	NULL
F	NULL
,	NULL
Gresser	NULL
,	NULL
I	NULL
:	NULL
The	NULL
neglected	NULL
role	NULL
of	NULL
type	NULL
I	NULL
interferon	NULL
in	NULL
the	NULL
T-cell	NULL
response	NULL
:	NULL
Implications	NULL
for	NULL
its	NULL
clinical	NULL
use	NULL
.	NULL

Immunol	NULL
Today	NULL
17:369	NULL
,	NULL
1996	NULL
3	NULL
.	NULL

Herbermann	NULL
RB	NULL
:	NULL
Effect	NULL
of	NULL
«	NULL
interferons	NULL
on	NULL
immune	NULL
function	NULL
.	NULL

Semin	NULL
Oncol	NULL
24:89	NULL
,	NULL
1997	NULL
4	NULL
.	NULL

Miller	NULL
U	NULL
,	NULL
Steinhoff	NULL
U	NULL
,	NULL
Reis	NULL
LF	NULL
,	NULL
Hemmi	NULL
S	NULL
,	NULL
Pavlovic	NULL
J	NULL
,	NULL
Zinkernagel	NULL
RM	NULL
,	NULL
Aguet	NULL
M	NULL
:	NULL
Functional	NULL
role	NULL
of	NULL
type	NULL
I	NULL
and	NULL
II	NULL
interferons	NULL
in	NULL
antiviral	NULL
response	NULL
.	NULL

Science	NULL
264:1918	NULL
,	NULL
1994	NULL
5	NULL
.	NULL

Rogge	NULL
L	NULL
,	NULL
Barberis-Maino	NULL
L	NULL
,	NULL
Biffi	NULL
M	NULL
,	NULL
Passini	NULL
N	NULL
,	NULL
Presky	NULL
DH	NULL
,	NULL
Gubler	NULL
U	NULL
,	NULL
Sinigaglia	NULL
F	NULL
:	NULL
Selective	NULL
expression	NULL
of	NULL
an	NULL
interleukin-12	NULL
receptor	NULL
component	NULL
by	NULL
human	NULL
T	NULL
helper	NULL
1	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
185:825	NULL
,	NULL
1997	NULL
6	NULL
.	NULL

Manetti	NULL
R	NULL
,	NULL
Annunziato	NULL
F	NULL
,	NULL
Tomasevic	NULL
L	NULL
,	NULL
Gianno	NULL
V	NULL
,	NULL
Parronchi	NULL
P	NULL
,	NULL
Romagnani	NULL
S	NULL
,	NULL
Maggi	NULL
E	NULL
:	NULL
Polyinosinic	NULL
acid	NULL
:	NULL
Polycytidylic	NULL
acid	NULL
promotes	NULL
T	NULL
helper	NULL
type	NULL
1-specific	NULL
immune	NULL
responses	NULL
by	NULL
stimulating	NULL
macrophage	NULL
production	NULL
of	NULL
interferon-alpha	NULL
and	NULL
interleukin-12	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
25:2656	NULL
,	NULL
1995	NULL
7	NULL
.	NULL

Sareneva	NULL
T	NULL
,	NULL
Matikainen	NULL
S	NULL
,	NULL
Kurimoto	NULL
M	NULL
,	NULL
Julkunen	NULL
I	NULL
:	NULL
Influenza	NULL
A	NULL
virus-induced	NULL
IFN-	NULL
@	NULL
/B	NULL
and	NULL
IL-18	NULL
synergistically	NULL
enhance	NULL
IFN-y	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
160:6032	NULL
,	NULL
1998	NULL
8	NULL
.	NULL

Hou	NULL
J	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Henzel	NULL
WJ	NULL
,	NULL
Wong	NULL
SC	NULL
,	NULL
McKnight	NULL
SL	NULL
:	NULL
Identification	NULL
and	NULL
purification	NULL
of	NULL
human	NULL
Stat	NULL
proteins	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
interleukin-2	NULL
.	NULL

Immunity	NULL
2:321	NULL
,	NULL
1995	NULL
9	NULL
.	NULL

Taniguchi	NULL
T	NULL
:	NULL
Cytokine	NULL
signaling	NULL
through	NULL
nonreceptor	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Science	NULL
268:251	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

O'Shea	NULL
JJ	NULL
:	NULL
Jaks	NULL
,	NULL
STATs	NULL
,	NULL
cytokine	NULL
signal	NULL
transduction	NULL
,	NULL
and	NULL
immunoregulation	NULL
:	NULL
Are	NULL
we	NULL
there	NULL
yet	NULL
?	NULL

Immunity	NULL
7:1	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1990	NULL
11	NULL
.	NULL

Waldmann	NULL
T	NULL
,	NULL
Tagaya	NULL
Y	NULL
,	NULL
Bamford	NULL
R	NULL
:	NULL
Interleukin-2	NULL
,	NULL
interleukin-15	NULL
,	NULL
and	NULL
their	NULL
receptors	NULL
.	NULL

Int	NULL
Rev	NULL
Immunol	NULL
16:205	NULL
,	NULL
1998	NULL
12	NULL
.	NULL

Fujii	NULL
H	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Kawahara	NULL
A	NULL
,	NULL
Mori	NULL
H	NULL
,	NULL
Gouilleux	NULL
F	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Minami	NULL
Y	NULL
,	NULL
Miyazaki	NULL
T	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Activation	NULL
of	NULL
STATS	NULL
by	NULL
interleukin	NULL
2	NULL
requires	NULL
a	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
B	NULL
chain	NULL
but	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
proliferative	NULL
signal	NULL
transmission	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:5482	NULL
,	NULL
1995	NULL
13	NULL
.	NULL

Friedmann	NULL
MC	NULL
,	NULL
Migone	NULL
TS	NULL
,	NULL
Russell	NULL
SM	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
Different	NULL
interleukin	NULL
2	NULL
receptor	NULL
B-chain	NULL
tyrosines	NULL
couple	NULL
to	NULL
at	NULL
least	NULL
two	NULL
signaling	NULL
pathways	NULL
and	NULL
synergistically	NULL
mediate	NULL
interleukin-2-induced	NULL
proliferation	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:2077	NULL
,	NULL
1996	NULL
14	NULL
.	NULL

Nakajima	NULL
H	NULL
,	NULL
Liu	NULL
X-W	NULL
,	NULL
Wynshaw-Boris	NULL
A	NULL
,	NULL
Rosenthal	NULL
LA	NULL
,	NULL
Imada	NULL
K	NULL
,	NULL
Finbloom	NULL
DS	NULL
,	NULL
Hennighausen	NULL
L	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
An	NULL
indirect	NULL
effect	NULL
of	NULL
STAT	NULL
5a	NULL
in	NULL
IL-2-induced	NULL
proliferation	NULL
:	NULL
A	NULL
critical	NULL
role	NULL
for	NULL
STAT5a	NULL
in	NULL
IL-2-mediated	NULL
IL-2	NULL
receptor	NULL
«	NULL
chain	NULL
induction	NULL
.	NULL

Immunity	NULL
7:691	NULL
,	NULL
1997	NULL
15	NULL
.	NULL

Sugamura	NULL
K	NULL
,	NULL
Asao	NULL
H	NULL
,	NULL
Kondo	NULL
M	NULL
,	NULL
Tanaka	NULL
N	NULL
,	NULL
Ishii	NULL
N	NULL
,	NULL
Ohbo	NULL
K	NULL
,	NULL
Nakamura	NULL
M	NULL
,	NULL
Takeshita	NULL
T	NULL
:	NULL
The	NULL
interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
:	NULL
its	NULL
role	NULL
in	NULL
the	NULL
multiple	NULL
cytokine	NULL
receptor	NULL
complexes	NULL
and	NULL
T	NULL
cell	NULL
development	NULL
in	NULL
XSCID	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
14:179	NULL
,	NULL
1996	NULL
16	NULL
.	NULL

Sharfe	NULL
N	NULL
,	NULL
Dadi	NULL
HK	NULL
,	NULL
Shahar	NULL
M	NULL
,	NULL
Roifman	NULL
CM	NULL
:	NULL
Human	NULL
immune	NULL
disorder	NULL
arising	NULL
from	NULL
mutation	NULL
of	NULL
the	NULL
«	NULL
chain	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:3168	NULL
,	NULL
1997	NULL
17	NULL
.	NULL

Dautry	NULL
FD	NULL
,	NULL
Weil	NULL
D	NULL
,	NULL
Yu	NULL
J	NULL
,	NULL
Dautry-Varsat	NULL
A	NULL
:	NULL
Regulation	NULL
of	NULL
pim	NULL
and	NULL
myb	NULL
mRNA	NULL
accumulation	NULL
by	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
3	NULL
in	NULL
murine	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
263:17615	NULL
,	NULL
1988	NULL
18	NULL
.	NULL

Koskinen	NULL
PJ	NULL
,	NULL
Alitalo	NULL
K	NULL
:	NULL
Role	NULL
of	NULL
myc	NULL
amplification	NULL
and	NULL
overexpression	NULL
in	NULL
cell	NULL
growth	NULL
,	NULL
differentiation	NULL
and	NULL
death	NULL
.	NULL

Semin	NULL
Cancer	NULL
Biol	NULL
4:3	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Meeker	NULL
TC	NULL
,	NULL
Nagarajan	NULL
L	NULL
,	NULL
ar-Rushdi	NULL
A	NULL
,	NULL
Rovera	NULL
G	NULL
,	NULL
Huebner	NULL
K	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
human	NULL
PIM-1	NULL
gene	NULL
:	NULL
A	NULL
putative	NULL
oncogene	NULL
coding	NULL
for	NULL
a	NULL
tissue	NULL
specific	NULL
member	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
family	NULL
.	NULL

Oncogene	NULL
Res	NULL
1:87	NULL
,	NULL
1987	NULL
20	NULL
.	NULL

Amson	NULL
R	NULL
,	NULL
Sigaux	NULL
F	NULL
,	NULL
Przedporski	NULL
S	NULL
,	NULL
Flandrin	NULL
G	NULL
,	NULL
Givol	NULL
D	NULL
,	NULL
Telerman	NULL
A	NULL
:	NULL
The	NULL
human	NULL
protooncogene	NULL
product	NULL
p33pim	NULL
is	NULL
expressed	NULL
during	NULL
fetal	NULL
hematopoiesis	NULL
and	NULL
in	NULL
diverse	NULL
leukemias	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:8857	NULL
,	NULL
1989	NULL
21	NULL
.	NULL

Méordy	NULL
T	NULL
,	NULL
Verbeek	NULL
S	NULL
,	NULL
Ma	NULL
S	NULL
,	NULL
Achacoso	NULL
P	NULL
,	NULL
Berns	NULL
A	NULL
,	NULL
Alt	NULL
F	NULL
:	NULL
Em	NULL
N-and	NULL
Em	NULL
L-myc	NULL
cooperate	NULL
with	NULL
Em-pim-1	NULL
to	NULL
generate	NULL
lymphoid	NULL
tumors	NULL
at	NULL
high	NULL
frequency	NULL
in	NULL
double-transgenic	NULL
mice	NULL
.	NULL

Oncogene	NULL
6:1941	NULL
,	NULL
1991	NULL
22	NULL
.	NULL

Verbeek	NULL
S	NULL
,	NULL
van	NULL
Lohuizen	NULL
M	NULL
,	NULL
van	NULL
der	NULL
Valk	NULL
M	NULL
,	NULL
Domen	NULL
J	NULL
,	NULL
Kraal	NULL
GP	NULL
,	NULL
Berns	NULL
A	NULL
:	NULL
Mice	NULL
bearing	NULL
the	NULL
Em-myc	NULL
and	NULL
Em-pim-1	NULL
transgene	NULL
develop	NULL
pre-B-cell	NULL
leukemia	NULL
prenatally	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:1176	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Acton	NULL
D	NULL
,	NULL
Domen	NULL
J	NULL
,	NULL
Jacobs	NULL
H	NULL
,	NULL
Vlaar	NULL
M	NULL
,	NULL
Korsmeyer	NULL
S	NULL
,	NULL
Berns	NULL
A	NULL
:	NULL
Collaboration	NULL
of	NULL
PIM-1	NULL
and	NULL
BCL-2	NULL
in	NULL
lymphomagenesis	NULL
.	NULL

Curr	NULL
Top	NULL
Microbiol	NULL
Immunol	NULL
182:293	NULL
,	NULL
1992	NULL
24	NULL
.	NULL

Domen	NULL
J	NULL
,	NULL
van	NULL
der	NULL
Lugt	NULL
NM	NULL
,	NULL
Acton	NULL
D	NULL
,	NULL
Laird	NULL
PW	NULL
,	NULL
Linders	NULL
K	NULL
,	NULL
Berns	NULL
A	NULL
:	NULL
Pim-1	NULL
levels	NULL
determine	NULL
the	NULL
size	NULL
of	NULL
early	NULL
B	NULL
lymphoid	NULL
compartments	NULL
in	NULL
bone	NULL
marrow	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
178:1665	NULL
,	NULL
1991	NULL
25	NULL
.	NULL

Méoroy	NULL
TA	NULL
,	NULL
Grzeschiczek	NULL
A	NULL
,	NULL
Petzold	NULL
S	NULL
,	NULL
Hartmann	NULL
K-U	NULL
:	NULL
Expression	NULL
of	NULL
a	NULL
pim-	NULL
]	NULL
transgene	NULL
accelerates	NULL
lymphoproliferation	NULL
and	NULL
inhibits	NULL
apoptosis	NULL
in	NULL
Ipr/lpr	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:10734	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Lilly	NULL
M	NULL
,	NULL
Kraft	NULL
A	NULL
:	NULL
Enforced	NULL
expression	NULL
of	NULL
the	NULL
M	NULL
,	NULL
33,000	NULL
pim-1	NULL
kinase	NULL
enhances	NULL
factor-independent	NULL
survival	NULL
and	NULL
inhibits	NULL
apoptosis	NULL
in	NULL
murine	NULL
myeloid	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
57:5348	NULL
,	NULL
1997	NULL
27	NULL
.	NULL

Chirgwin	NULL
JM	NULL
,	NULL
Przybyla	NULL
AE	NULL
,	NULL
MacDonald	NULL
RJ	NULL
,	NULL
Rutter	NULL
WJ	NULL
:	NULL
Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
,	NULL
1979	NULL
28	NULL
.	NULL

Glisin	NULL
V	NULL
,	NULL
Crkvenjankov	NULL
R	NULL
,	NULL
Byus	NULL
C	NULL
:	NULL
Ribonucleic	NULL
acid	NULL
isolated	NULL
by	NULL
cesium	NULL
chloride	NULL
centrifugation	NULL
.	NULL

Biochemistry	NULL
13:2633	NULL
,	NULL
1974	NULL
29	NULL
.	NULL

Andrews	NULL
NC	NULL
,	NULL
Faller	NULL
DV	NULL
:	NULL
A	NULL
rapid	NULL
micropreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
limited	NULL
numbers	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
19:2499	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Matikainen	NULL
S	NULL
,	NULL
Ronni	NULL
T	NULL
,	NULL
Hurme	NULL
M	NULL
,	NULL
Pine	NULL
R	NULL
,	NULL
Julkunen	NULL
I	NULL
:	NULL
Retinoic	NULL
MATIKAINEN	NULL
ET	NULL
AL	NULL
acid	NULL
activates	NULL
interferon	NULL
regulatory	NULL
factor-1	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
88:114	NULL
,	NULL
1996	NULL
31	NULL
.	NULL

Laemmli	NULL
UK	NULL
:	NULL
Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
227:680	NULL
,	NULL
1970	NULL
32	NULL
.	NULL

Tough	NULL
DF	NULL
,	NULL
Borrow	NULL
P	NULL
,	NULL
Sprent	NULL
J	NULL
:	NULL
Induction	NULL
of	NULL
bystander	NULL
T	NULL
cell	NULL
proliferation	NULL
by	NULL
viruses	NULL
and	NULL
type	NULL
I	NULL
interferon	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
272:1947	NULL
,	NULL
1996	NULL
33	NULL
.	NULL

Decker	NULL
T	NULL
,	NULL
Kovarik	NULL
P	NULL
,	NULL
Meinke	NULL
A	NULL
:	NULL
GAS	NULL
elements	NULL
:	NULL
A	NULL
few	NULL
nucleo-tides	NULL
with	NULL
a	NULL
major	NULL
impact	NULL
on	NULL
cytokine-induced	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
17:121	NULL
,	NULL
1997	NULL
34	NULL
.	NULL

John	NULL
S	NULL
,	NULL
Robbins	NULL
CM	NULL
,	NULL
Leonard	NULL
WJ	NULL
:	NULL
An	NULL
IL-2	NULL
response	NULL
element	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
promoter	NULL
is	NULL
a	NULL
composite	NULL
element	NULL
that	NULL
binds	NULL
STATS	NULL
,	NULL
Elf-1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
and	NULL
a	NULL
GATA	NULL
family	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
15:5627	NULL
,	NULL
1996	NULL
35	NULL
.	NULL

Lecine	NULL
P	NULL
,	NULL
Algarte	NULL
M	NULL
,	NULL
Rameil	NULL
P	NULL
,	NULL
Beadling	NULL
C	NULL
,	NULL
Bucher	NULL
P	NULL
,	NULL
Nabholz	NULL
M	NULL
,	NULL
Imbert	NULL
J	NULL
;	NULL
Elf-1	NULL
and	NULL
STATS	NULL
bind	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
new	NULL
enhancer	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
gene	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:6829	NULL
,	NULL
1996	NULL
36	NULL
.	NULL

Yip-Schneider	NULL
MT	NULL
,	NULL
Horie	NULL
M	NULL
,	NULL
Broxmeyer	NULL
HE	NULL
:	NULL
Transcriptional	NULL
induction	NULL
of	NULL
pim-1	NULL
protein	NULL
kinase	NULL
gene	NULL
expression	NULL
by	NULL
interferon-gamma	NULL
and	NULL
posttranscriptional	NULL
effects	NULL
on	NULL
costimulation	NULL
with	NULL
steel	NULL
factor	NULL
.	NULL

Blood	NULL
85:3494	NULL
,	NULL
1995	NULL
37	NULL
.	NULL

Meinke	NULL
A	NULL
,	NULL
Barahmand-Pour	NULL
F	NULL
,	NULL
Wohrl	NULL
S	NULL
,	NULL
Stoiber	NULL
D	NULL
,	NULL
Decker	NULL
T	NULL
:	NULL
Activation	NULL
of	NULL
different	NULL
STATS	NULL
isoforms	NULL
contributes	NULL
to	NULL
cell-type-restricted	NULL
signaling	NULL
in	NULL
response	NULL
to	NULL
interferons	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:6937	NULL
,	NULL
1996	NULL
38	NULL
.	NULL

Eilers	NULL
A	NULL
,	NULL
Baccarini	NULL
M	NULL
,	NULL
Horn	NULL
F	NULL
,	NULL
Hipskind	NULL
RA	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Decker	NULL
T	NULL
:	NULL
A	NULL
factor	NULL
induced	NULL
by	NULL
differentiation	NULL
signals	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
macrophage	NULL
lineage	NULL
binds	NULL
to	NULL
the	NULL
gamma	NULL
interferon	NULL
activation	NULL
site	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1364	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Durbin	NULL
,	NULL
JE	NULL
,	NULL
Hackenmiller	NULL
R	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Levy	NULL
DE	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
mouse	NULL
STAT1	NULL
gene	NULL
results	NULL
in	NULL
compromised	NULL
innate	NULL
immunity	NULL
to	NULL
viral	NULL
disease	NULL
.	NULL

Cell	NULL
84:443	NULL
,	NULL
1996	NULL
40	NULL
.	NULL

Meraz	NULL
MA	NULL
,	NULL
White	NULL
JM	NULL
,	NULL
Sheehan	NULL
KC	NULL
,	NULL
Bach	NULL
EA	NULL
,	NULL
Rodig	NULL
SJ	NULL
,	NULL
Dighe	NULL
AS	NULL
,	NULL
Kaplan	NULL
DH	NULL
,	NULL
Riley	NULL
JK	NULL
,	NULL
Greenlund	NULL
AC	NULL
,	NULL
Campbell	NULL
D	NULL
,	NULL
Carver-Moore	NULL
K	NULL
,	NULL
DuBois	NULL
RN	NULL
,	NULL
Clark	NULL
R	NULL
,	NULL
Aguet	NULL
M	NULL
,	NULL
Schreiber	NULL
RD	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
STAT1	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
84:431	NULL
,	NULL
1996	NULL
41	NULL
.	NULL

Cirelli	NULL
R	NULL
,	NULL
Tyring	NULL
SK	NULL
:	NULL
Major	NULL
therapeutic	NULL
uses	NULL
of	NULL
interferons	NULL
.	NULL

Clin	NULL
Immunother	NULL
3:27	NULL
,	NULL
1995	NULL
42	NULL
.	NULL

Joneja	NULL
B	NULL
,	NULL
Wojchowski	NULL
DM	NULL
:	NULL
Mitogenic	NULL
signaling	NULL
and	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
via	NULL
erythropoietin	NULL
receptor	NULL
box-1	NULL
domain	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:11176	NULL
,	NULL
1997	NULL
43	NULL
.	NULL

Sakai	NULL
I	NULL
,	NULL
Kraft	NULL
AS	NULL
:	NULL
The	NULL
kinase	NULL
domain	NULL
of	NULL
Jak2	NULL
mediates	NULL
induction	NULL
of	NULL
Bel-2	NULL
and	NULL
delays	NULL
cell	NULL
death	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:12350	NULL
,	NULL
1997	NULL
44	NULL
.	NULL

Meyer	NULL
WK-H	NULL
,	NULL
Reichenbach	NULL
P	NULL
,	NULL
Schindler	NULL
U	NULL
,	NULL
Soldaini	NULL
E	NULL
,	NULL
Nabholz	NULL
M	NULL
:	NULL
Interaction	NULL
of	NULL
STATS	NULL
dimers	NULL
on	NULL
two	NULL
low	NULL
affinity	NULL
sites	NULL
mediates	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
stimulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
272:31821	NULL
,	NULL
1997	NULL
45	NULL
.	NULL

Xu	NULL
X	NULL
,	NULL
Sun	NULL
Y-L	NULL
,	NULL
Hoey	NULL
T	NULL
:	NULL
Cooperative	NULL
DNA	NULL
binding	NULL
and	NULL
sequence-selective	NULL
recognition	NULL
conferred	NULL
by	NULL
the	NULL
STAT	NULL
amino-terminal	NULL
domain	NULL
.	NULL

Science	NULL
273:794	NULL
,	NULL
1996	NULL
46	NULL
.	NULL

Vinkemeir	NULL
U	NULL
,	NULL
Cohen	NULL
SL	NULL
,	NULL
Moarefi	NULL
I	NULL
,	NULL
Chait	NULL
BT	NULL
,	NULL
Kuriyan	NULL
J	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
DNA	NULL
binding	NULL
of	NULL
in	NULL
vifro	NULL
activated	NULL
STATle	NULL
,	NULL
STATIB	NULL
,	NULL
and	NULL
truncated	NULL
STAT1	NULL
:	NULL
Interaction	NULL
between	NULL
NH	NULL
;	NULL
-terminal	NULL
domains	NULL
stabilizes	NULL
binding	NULL
of	NULL
two	NULL
dimers	NULL
to	NULL
tandem	NULL
DNA	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
15:5616	NULL
,	NULL
1996	NULL
47	NULL
.	NULL

Azzoni	NULL
A	NULL
,	NULL
Kanakaraj	NULL
P	NULL
,	NULL
Zatsepina	NULL
O	NULL
,	NULL
Perussia	NULL
B	NULL
:	NULL
IL-12-induced	NULL
activation	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cells	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
immediate-early	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
157:3235	NULL
,	NULL
1997	NULL
48	NULL
.	NULL

Miyazaki	NULL
T	NULL
,	NULL
Kawahara	NULL
A	NULL
,	NULL
Fujii	NULL
H	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Minami	NULL
Y	NULL
,	NULL
Liu	NULL
Z-J	NULL
,	NULL
Oishi	NULL
I	NULL
,	NULL
Silvennoinen	NULL
O	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Ihle	NULL
JN	NULL
,	NULL
Taniguchi	NULL
T	NULL
:	NULL
Functional	NULL
activation	NULL
of	NULL
Jak1	NULL
and	NULL
Jak3	NULL
by	NULL
selective	NULL
association	NULL
with	NULL
IL-2	NULL
receptor	NULL
subunits	NULL
.	NULL

Science	NULL
266:1045	NULL
,	NULL
1994	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

INF-	NULL
«	NULL
ACTIVATES	NULL
MULTIPLE	NULL
STAT	NULL
PROTEINS	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
49	NULL
.	NULL

Schindler	NULL
C	NULL
,	NULL
Darnell	NULL
JE	NULL
Jr	NULL
:	NULL
Transcriptional	NULL
responses	NULL
to	NULL
polypep-tide	NULL
ligands	NULL
:	NULL
The	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
64:621	NULL
,	NULL
1995	NULL
50	NULL
.	NULL

Harroch	NULL
S	NULL
,	NULL
Revel	NULL
M	NULL
,	NULL
Chebath	NULL
J	NULL
:	NULL
Interleukin-6	NULL
signaling	NULL
via	NULL
transcription	NULL
factors	NULL
binding	NULL
palindromic	NULL
enhancers	NULL
of	NULL
different	NULL
genes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:26191	NULL
,	NULL
1994	NULL
51	NULL
.	NULL

Raz	NULL
J	NULL
,	NULL
Durbin	NULL
E	NULL
,	NULL
Levy	NULL
DE	NULL
:	NULL
Acute	NULL
phase	NULL
response	NULL
factor	NULL
and	NULL
additional	NULL
members	NULL
of	NULL
the	NULL
interferon-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
family	NULL
integrate	NULL
diverse	NULL
signals	NULL
from	NULL
cytokines	NULL
,	NULL
interferons	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
269:24391	NULL
,	NULL
1994	NULL
52	NULL
.	NULL

Yang	NULL
C-H	NULL
,	NULL
Shi	NULL
W	NULL
,	NULL
Basu	NULL
L	NULL
,	NULL
Murti	NULL
A	NULL
,	NULL
Constantinescu	NULL
SN	NULL
,	NULL
Blatt	NULL
L	NULL
,	NULL
Croze	NULL
E	NULL
,	NULL
Mullersman	NULL
JE	NULL
,	NULL
Pfeffer	NULL
LM	NULL
:	NULL
Direct	NULL
association	NULL
of	NULL
STAT3	NULL
with	NULL
1991	NULL
the	NULL
IFNAR-1	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
type	NULL
I	NULL
interferon	NULL
receptor	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
271:8057	NULL
,	NULL
1996	NULL
53	NULL
.	NULL

Cho	NULL
SS	NULL
,	NULL
Bacon	NULL
CM	NULL
,	NULL
Sudarshan	NULL
C	NULL
,	NULL
Rees	NULL
RC	NULL
,	NULL
Finbloom	NULL
D	NULL
,	NULL
Pine	NULL
R	NULL
,	NULL
O'Shea	NULL
JJ	NULL
:	NULL
Activation	NULL
of	NULL
STAT4	NULL
by	NULL
IL-12	NULL
and	NULL
IFN-	NULL
«	NULL
:	NULL
Evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
ligand-induced	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

J	NULL
Immunol	NULL
157:4781	NULL
,	NULL
1996	NULL
54	NULL
.	NULL

Lehtonen	NULL
A	NULL
,	NULL
Matikainen	NULL
S	NULL
,	NULL
Julkunen	NULL
I	NULL
:	NULL
Interferons	NULL
up-regulate	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
and	NULL
IRF	NULL
family	NULL
transcription	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

J	NULL
Immunol	NULL
159:794	NULL
,	NULL
1997	NULL
55	NULL
.	NULL

Isaacs	NULL
A	NULL
,	NULL
Lindenmann	NULL
J	NULL
:	NULL
Virus	NULL
interference	NULL
I	NULL
.	NULL

The	NULL
interferon	NULL
.	NULL

Proc	NULL
Soc	NULL
Lond	NULL
147:258	NULL
,	NULL
1957	NULL
Virus-associated	NULL
hemophagocytic	NULL
syndrome	NULL
.	NULL

A	NULL
healthy	NULL
18-year-old	NULL
senior	NULL
high	NULL
school	NULL
student	NULL
presented	NULL
with	NULL
several	NULL
weeks	NULL
of	NULL
myalgias	NULL
,	NULL
fevers	NULL
,	NULL
and	NULL
sore	NULL
throat	NULL
.	NULL

She	NULL
subsequently	NULL
developed	NULL
pancytopenia	NULL
and	NULL
hepatic	NULL
dysfunction	NULL
.	NULL

A	NULL
thorough	NULL
evaluation	NULL
was	NULL
unrevealing	NULL
except	NULL
for	NULL
a	NULL
positive	NULL
monospot	NULL
and	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
VCA-IgG	NULL
with	NULL
a	NULL
negative	NULL
EBV	NULL
VCA-IgG	NULL
and	NULL
EBNA	NULL
(	NULL
both	NULL
became	NULL
positive	NULL
several	NULL
weeks	NULL
later	NULL
)	NULL
.	NULL

A	NULL
diagnosis	NULL
of	NULL
acute	NULL
EBV	NULL
infection	NULL
was	NULL
made	NULL
.	NULL

Over	NULL
the	NULL
next	NULL
3	NULL
weeks	NULL
she	NULL
had	NULL
a	NULL
waxing	NULL
and	NULL
waning	NULL
course	NULL
but	NULL
finally	NULL
required	NULL
hospital	NULL
admission	NULL
due	NULL
to	NULL
worsening	NULL
pancytopenia	NULL
(	NULL
WBC	NULL
,	NULL
300/	NULL
pL	NULL
;	NULL
hematocrit	NULL
,	NULL
16.2	NULL
%	NULL
;	NULL
and	NULL
platelet	NULL
count	NULL
,	NULL
44,000	NULL
,	NULL
gL	NULL
)	NULL
and	NULL
hepatic	NULL
dysfunction	NULL
(	NULL
ALT	NULL
,	NULL
636	NULL
U/	NULL
L	NULL
;	NULL
AST	NULL
,	NULL
608	NULL
U/L	NULL
;	NULL
LDH	NULL
,	NULL
2,788	NULL
U/L	NULL
;	NULL
direct	NULL
bilirubin	NULL
,	NULL
32.2	NULL
mg/dL	NULL
;	NULL
and	NULL
prothrombin	NULL
time	NULL
,	NULL
16	NULL
seconds	NULL
)	NULL
.	NULL

Her	NULL
physical	NULL
exam	NULL
was	NULL
notable	NULL
for	NULL
a	NULL
fever	NULL
(	NULL
39.5°C	NULL
)	NULL
,	NULL
a	NULL
diffuse	NULL
fine	NULL
scaly	NULL
rash	NULL
,	NULL
severe	NULL
icterus	NULL
,	NULL
no	NULL
adenopathy	NULL
,	NULL
a	NULL
liver	NULL
span	NULL
of	NULL
14	NULL
cm	NULL
in	NULL
the	NULL
midclavicular	NULL
line	NULL
,	NULL
and	NULL
a	NULL
spleen	NULL
tip	NULL
palpable	NULL
2	NULL
cm	NULL
below	NULL
the	NULL
costal	NULL
margin	NULL
.	NULL

Biopsy	NULL
of	NULL
her	NULL
bone	NULL
marrow	NULL
showed	NULL
overall	NULL
hypocellularity	NULL
with	NULL
multiple	NULL
nests	NULL
of	NULL
RBCs	NULL
(	NULL
arrow	NULL
s	NULL
in	NULL
figure	NULL
on	NULL
left	NULL
;	NULL
original	NULL
magnification	NULL
x100	NULL
)	NULL
.	NULL

These	NULL
nests	NULL
of	NULL
RBCs	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
aspirate	NULL
(	NULL
figure	NULL
on	NULL
right	NULL
;	NULL
original	NULL
magnification	NULL
x2,500	NULL
)	NULL
,	NULL
represent	NULL
histiocytes	NULL
with	NULL
engulfed	NULL
erythrocytes	NULL
characteristic	NULL
of	NULL
hemophagocytosis	NULL
.	NULL

Despite	NULL
intense	NULL
im	NULL
munosuppressive	NULL
therapy	NULL
(	NULL
including	NULL
steroids	NULL
,	NULL
cyclosporin	NULL
A	NULL
,	NULL
IVIG	NULL
,	NULL
and	NULL
ATG	NULL
)	NULL
,	NULL
she	NULL
developed	NULL
respiratory	NULL
failure	NULL
,	NULL
gastrointestinal	NULL
bleeding	NULL
,	NULL
renal	NULL
failure	NULL
(	NULL
requiring	NULL
dialysis	NULL
)	NULL
,	NULL
cardiac	NULL
dysfunction	NULL
(	NULL
with	NULL
global	NULL
hypokinesis	NULL
)	NULL
,	NULL
and	NULL
pancreatitis	NULL
.	NULL

She	NULL
finally	NULL
succumbed	NULL
to	NULL
an	NULL
intracranial	NULL
hemorrhage	NULL
.	NULL

Virus-associated	NULL
hemophagocytic	NULL
syndrome	NULL
is	NULL
typically	NULL
associated	NULL
with	NULL
acute	NULL
EBV	NULL
infection	NULL
.	NULL

It	NULL
is	NULL
characterized	NULL
by	NULL
constitutional	NULL
symptoms	NULL
,	NULL
including	NULL
fever	NULL
,	NULL
rash	NULL
,	NULL
lymphadenopathy	NULL
,	NULL
and	NULL
hepatospleno-megaly	NULL
.	NULL

Therapy	NULL
is	NULL
directed	NULL
at	NULL
the	NULL
immune	NULL
dysregulation	NULL
and	NULL
is	NULL
often	NULL
ineffective	NULL
,	NULL
as	NULL
in	NULL
this	NULL
unfortunate	NULL
case	NULL
.	NULL

(	NULL
Courtesy	NULL
of	NULL
Lindsey	NULL
Baden	NULL
,	NULL
MD	NULL
,	NULL
and	NULL
Frank	NULL
Evangelista	NULL
,	NULL
MD	NULL
,	NULL
Beth	NULL
Israel	NULL
Deaconess	NULL
Medical	NULL
Center	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pathology	NULL
,	NULL
330	NULL
Brookline	NULL
Ave	NULL
,	NULL
SL-435	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
.	NULL
)	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1999	NULL
93	NULL
:	NULL
1980-1991	NULL
Interferon-	NULL
?	NULL

Activates	NULL
Multiple	NULL
STAT	NULL
Proteins	NULL
and	NULL
Upregulates	NULL
Proliferation-Associated	NULL
IL-2R	NULL
?	NULL

,	NULL
c-myc	NULL
,	NULL
and	NULL
pim-1	NULL
Genes	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
Sampsa	NULL
Matikainen	NULL
,	NULL
Timo	NULL
Sareneva	NULL
,	NULL
Tapani	NULL
Ronni	NULL
,	NULL
Anne	NULL
Lehtonen	NULL
,	NULL
Paivi	NULL
J.	NULL
Koskinen	NULL
and	NULL
Ilkka	NULL
Julkunen	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtow®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/6/1980.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Immunobiology	NULL
and	NULL
Immunotherapy	NULL
(	NULL
5678	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

